DPD_drug_code,DPD_class,DPD_DIN,DPD_brand_name,DPD_company,opioid_agonist_flag,prescribed_alternative_flag,number_active_ingred,Virtual_prod_code_system,Virtual_prod_code,Virtual_prod_name,ATC_Code,ATC_name,DPD_status,DPD_status_date
99638,Human,02506963,Fentanyl Citrate Injection,Jamp Pharma Corporation,,,1,CCDD_NTP,9000323,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule,N01AH01,Fentanyl,Marketed,2022-06-06
99638,Human,02506963,Fentanyl Citrate Injection,Jamp Pharma Corporation,,,1,CCDD_NTP,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,N01AH01,Fentanyl,Marketed,2022-06-06
86987,Human,02384124,Fentanyl Citrate Injection Sdz,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,N01AH01,Fentanyl,Marketed,2021-01-19
86987,Human,02384124,Fentanyl Citrate Injection Sdz,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000323,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule,N01AH01,Fentanyl,Marketed,2021-01-19
43842,Human,02126648,Fentanyl Citrate Injection U.S.P.-Liq Iv Im Epd,Hospira Healthcare Ulc,,,1,BC_MOH,,fentanyl (fentanyl citrate) 50 mcg / mL solution for injection,N01AH01,Fentanyl,Cancelled post market,2011-08-05
12664,Human,00888346,Fentanyl Citrate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,N01AH01,Fentanyl,Cancelled post market,2020-01-06
12664,Human,00888346,Fentanyl Citrate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000322,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection ampoule,N01AH01,Fentanyl,Cancelled post market,2020-01-06
12664,Human,00888346,Fentanyl Citrate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000323,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule,N01AH01,Fentanyl,Cancelled post market,2020-01-06
12664,Human,00888346,Fentanyl Citrate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000319,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection ampoule,N01AH01,Fentanyl,Cancelled post market,2020-01-06
12664,Human,00888346,Fentanyl Citrate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000324,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial,N01AH01,Fentanyl,Cancelled post market,2020-01-06
12664,Human,00888346,Fentanyl Citrate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,N01AH01,Fentanyl,Cancelled post market,2020-01-06
63983,Human,02240434,Fentanyl Citrate Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,N01AH01,Fentanyl,Marketed,2005-08-26
63983,Human,02240434,Fentanyl Citrate Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2005-08-26
63983,Human,02240434,Fentanyl Citrate Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000324,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2005-08-26
63983,Human,02240434,Fentanyl Citrate Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2005-08-26
63983,Human,02240434,Fentanyl Citrate Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,N01AH01,Fentanyl,Marketed,2005-08-26
87103,Human,02385406,Fentanyl Citrate Injection Usp,Hikma Canada Limited,,,1,CCDD_NTP,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,N01AH01,Fentanyl,Dormant,2024-10-05
87103,Human,02385406,Fentanyl Citrate Injection Usp,Hikma Canada Limited,,,1,CCDD_NTP,9000323,fentanyl (fentanyl citrate) 500 mcg per 10 mL solution for injection ampoule,N01AH01,Fentanyl,Dormant,2024-10-05
14520,Human,01988778,Fentanyl Citrate Injection Usp 50Mcg/Ml,David Bull Laboratories (Canada) Inc.,,,1,BC_MOH,,fentanyl (fentanyl citrate) 50 mcg / mL liquid for injection,N01AH01,Fentanyl,Cancelled post market,1999-08-04
99116,Human,02501554,"Fentanyl Citrate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9014567,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2021-06-18
99116,Human,02501554,"Fentanyl Citrate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2021-06-18
99116,Human,02501554,"Fentanyl Citrate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9014568,fentanyl (fentanyl citrate) 50 mcg per 1 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2021-06-18
99116,Human,02501554,"Fentanyl Citrate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,N01AH01,Fentanyl,Marketed,2021-06-18
99116,Human,02501554,"Fentanyl Citrate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2021-06-18
98602,Human,02496143,Fentanyl Injection Bp,Sterimax Inc,,,1,CCDD_NTP,9000321,fentanyl (fentanyl citrate) 100 mcg per 2 mL solution for injection ampoule,N01AH01,Fentanyl,Marketed,2020-09-09
98603,Human,02496151,Fentanyl Injection Bp,Sterimax Inc,,,1,CCDD_NTP,9000885,fentanyl (fentanyl citrate) 250 mcg per 5 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2020-04-23
98604,Human,02496178,Fentanyl Injection Bp,Sterimax Inc,,,1,CCDD_NTP,9000320,fentanyl (fentanyl citrate) 1000 mcg per 20 mL solution for injection vial,N01AH01,Fentanyl,Marketed,2020-04-23
98605,Human,02496186,Fentanyl Injection Bp,Sterimax Inc,,,1,CCDD_NTP,9014297,fentanyl (fentanyl citrate) 50 mcg per mL solution for injection 50 mL vial,N01AH01,Fentanyl,Marketed,2020-04-23
8180,Human,00751251,Sublimaze Inj 50Mcg/Ml,"Janssen Pharmaceutica, Division Of Janssen-Ortho Inc.",,,1,BC_MOH,,fentanyl citrate 50 mcg / mL liquid for injection,N01AH01,Fentanyl,Cancelled post market,1996-09-10
8206,Human,00755818,Alfenta Inj 500Mcg/Ml,Janssen Inc,,,1,BC_MOH,,alfentanil (alfentanil hydrochloride) 500 mcg / mL solution for injection,N01AH02,Alfentanil,Cancelled post market,2008-09-05
72517,Human,02248181,Alfentanil Injection Usp,Sandoz Canada Incorporated,,,1,BC_MOH,,alfentanil (alfentanil hydrochloride) 500 mcg / mL solution for injection,N01AH02,Alfentanil,Cancelled post market,2019-08-01
6468,Human,00619744,Sufenta Inj 50Mcg/Ml,"Janssen Pharmaceutica, Division Of Janssen-Ortho Inc.",,1,1,BC_MOH,,sufentanil (sufentanil citrate) 50 mcg / mL liquid for injection,N01AH03,Sufentanil,Cancelled post market,1996-09-10
16449,Human,01951319,Sufenta Inj 50Mcg/Ml,Janssen Inc,,1,1,BC_MOH,,sufentanil (sufentanil citrate) 50 mcg / mL liquid for injection,N01AH03,Sufentanil,Cancelled post market,2007-11-26
97364,Human,02483181,Sufentanil Citrate Injection,Hikma Canada Limited,,1,1,BC_MOH,,sufentanil (sufentanil citrate) 50 mcg / mL solution for injection,N01AH03,Sufentanil,Approved,2022-06-07
68108,Human,02244147,Sufentanil Citrate Injection Usp,Sandoz Canada Incorporated,,1,1,CCDD_NTP,9013354,sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule,N01AH03,Sufentanil,Marketed,2005-09-27
68108,Human,02244147,Sufentanil Citrate Injection Usp,Sandoz Canada Incorporated,,1,1,CCDD_NTP,9013353,sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection vial,N01AH03,Sufentanil,Marketed,2005-09-27
92657,Human,02442213,Sufentanil Citrate Injection Usp,Sterimax Inc,,1,1,CCDD_NTP,9013354,sufentanil (sufentanil citrate) 50 mcg per 1 mL solution for injection ampoule,N01AH03,Sufentanil,Marketed,2019-05-27
92657,Human,02442213,Sufentanil Citrate Injection Usp,Sterimax Inc,,1,1,CCDD_NTP,9013352,sufentanil (sufentanil citrate) 250 mcg per 5 mL solution for injection ampoule,N01AH03,Sufentanil,Marketed,2019-05-27
155,Human,00009857,Leritine Inj 25Mg/Ml,"Merck Frosst Canada & Cie, Merck Frosst Canada & Co.",,,1,BC_MOH,,anileridine (anileridine phosphate) 25 mg / mL liquid for injection,N01AH05,Anileridine,Cancelled post market,2000-06-14
154,Human,00010014,Leritine Tablets 25Mg,"Merck Frosst Canada & Cie, Merck Frosst Canada & Co.",,,1,BC_MOH,,anileridine (anileridine hydrochloride) 25 mg / tablet oral tablet,N01AH05,Anileridine,Cancelled post market,2001-06-01
4827,Human,00554243,Innovar Inj,"Janssen Pharmaceutica, Division Of Janssen-Ortho Inc.",,,2,BC_MOH,,droperidol 2.5 mg / mL + fentanyl citrate 0.05 mg / mL liquid for injection,N01AH51,"Fentanyl, combinations",Cancelled post market,1996-09-10
94034,Human,02453800,Bar-Morphine Sr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,morphine sulfate 15 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2024-04-08
94036,Human,02453827,Bar-Morphine Sr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,morphine sulfate 30 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2024-04-08
94038,Human,02453843,Bar-Morphine Sr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,morphine sulfate 60 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2024-04-08
94039,Human,02453851,Bar-Morphine Sr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,morphine sulfate 100 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2024-04-08
94040,Human,02453878,Bar-Morphine Sr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,morphine sulfate 200 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2024-04-08
6171,Human,00614491,Doloral Sirop,Laboratoire Atlas Inc,,,1,CCDD_NTP,9000209,morphine hydrochloride 1 mg per mL syrup,N02AA01,Morphine,Marketed,2025-03-12
11597,Human,00614505,Doloral Sirop,Laboratoire Atlas Inc,,,1,CCDD_NTP,9000228,morphine hydrochloride 5 mg per mL syrup,N02AA01,Morphine,Marketed,2025-03-12
42846,Human,02184435,Kadian,Bgp Pharma Ulc,1,,1,CCDD_NTP,9000665,morphine sulfate 20 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2016-05-26
42847,Human,02184443,Kadian,Bgp Pharma Ulc,1,,1,CCDD_NTP,9000664,morphine sulfate 50 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2016-05-26
42848,Human,02184451,Kadian,Bgp Pharma Ulc,1,,1,CCDD_NTP,9000474,morphine sulfate 100 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2016-08-09
65841,Human,02242163,Kadian,Bgp Pharma Ulc,1,,1,CCDD_NTP,9000476,morphine sulfate 10 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2016-05-26
106285,Human,02559722,Kadian,Bgp Pharma Ulc,,,1,BC_MOH,,morphine sulfate 200 mg oral prolonged-release capsule,N02AA01,Morphine,Approved,2025-07-25
80582,Human,02320398,M-Ediat,Ethypharm Inc,,,1,CCDD_NTP,9001466,morphine sulfate 5 mg oral capsule,N02AA01,Morphine,Marketed,2025-06-13
80584,Human,02320428,M-Ediat,Ethypharm Inc,,,1,CCDD_NTP,9001463,morphine sulfate 10 mg oral capsule,N02AA01,Morphine,Marketed,2025-06-13
80585,Human,02320436,M-Ediat,Ethypharm Inc,,,1,CCDD_NTP,9001464,morphine sulfate 20 mg oral capsule,N02AA01,Morphine,Marketed,2025-06-13
80586,Human,02320444,M-Ediat,Ethypharm Inc,,,1,CCDD_NTP,9001465,morphine sulfate 30 mg oral capsule,N02AA01,Morphine,Marketed,2025-06-13
14502,Human,02019949,M-Eslon,Ethypharm Inc,,,1,CCDD_NTP,9000479,morphine sulfate 30 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2006-08-07
14541,Human,02019965,M-Eslon,Ethypharm Inc,,,1,CCDD_NTP,9000474,morphine sulfate 100 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2006-08-17
14542,Human,02019957,M-Eslon,Ethypharm Inc,,,1,CCDD_NTP,9000481,morphine sulfate 60 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2006-07-31
14543,Human,02019930,M-Eslon,Ethypharm Inc,,,1,CCDD_NTP,9000476,morphine sulfate 10 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2006-08-22
18877,Human,02177757,M-Eslon,Ethypharm Inc,,,1,CCDD_NTP,9000618,morphine sulfate 200 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2006-09-05
18878,Human,02177749,M-Eslon,Ethypharm Inc,,,1,CCDD_NTP,9000617,morphine sulfate 15 mg prolonged-release oral capsule,N02AA01,Morphine,Marketed,2006-07-17
6183,Human,00632503,M.O.S. 10 Syrup 10Mg/Ml,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 10 mg / mL oral syrup,N02AA01,Morphine,Cancelled post market,2014-07-30
6733,Human,00690198,M.O.S. 10 Tablets 10Mg,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 10 mg oral tablet,N02AA01,Morphine,Cancelled post market,2014-07-30
6182,Human,00632481,M.O.S. 20 Concentrate 20Mg/Ml,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 20 mg / mL oral syrup,N02AA01,Morphine,Cancelled post market,2014-07-30
8595,Human,00776181,M.O.S. Sr Tablets 30Mg,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 30 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2016-07-08
8596,Human,00776203,M.O.S. Sr Tablets 60Mg,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 60 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2016-07-08
14110,Human,02009765,M.O.S. Sulphate 10Mg Tab,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine sulfate 10 mg oral tablet,N02AA01,Morphine,Cancelled post market,2016-07-08
14107,Human,02009749,M.O.S. Sulphate 25Mg Tab,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine sulfate 25 mg oral tablet,N02AA01,Morphine,Cancelled post market,2016-07-08
14108,Human,02009706,M.O.S. Sulphate 50Mg Tab,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine sulfate 50 mg oral tablet,N02AA01,Morphine,Cancelled post market,2016-07-08
14111,Human,02009773,M.O.S. Sulphate 5Mg Tab,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine sulfate 5 mg oral tablet,N02AA01,Morphine,Cancelled post market,2016-07-08
3752,Human,00486582,M.O.S. Syrup 1.0 Mg/Ml,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 1 mg / mL oral syrup,N02AA01,Morphine,Cancelled post market,2014-07-30
4297,Human,00514217,M.O.S. Syrup 5Mg/Ml,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 5 mg / mL oral syrup,N02AA01,Morphine,Cancelled post market,2014-07-30
5846,Human,00624268,M.O.S.- 10,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 10 mg rectal suppository,N02AA01,Morphine,Cancelled post market,2014-07-30
5847,Human,00624276,M.O.S.- 20,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 20 mg rectal suppository,N02AA01,Morphine,Cancelled post market,2014-07-30
6122,Human,00636681,M.O.S.- 30,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 30 mg rectal suppository,N02AA01,Morphine,Cancelled post market,2014-07-30
6734,Human,00690201,M.O.S.-20 Tab 20Mg,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 20 mg oral tablet,N02AA01,Morphine,Cancelled post market,2014-07-30
6735,Human,00690228,M.O.S.-40 Tab 40Mg,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 40 mg oral tablet,N02AA01,Morphine,Cancelled post market,2014-07-30
6736,Human,00690236,M.O.S.-50 Concentrate Liq 50Mg/Ml,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 50 mg / mL oral syrup,N02AA01,Morphine,Cancelled post market,2014-07-30
6737,Human,00690244,M.O.S.-60 Tab 60Mg,Valeant Canada Lp / Valeant Canada S.E.C.,,,1,BC_MOH,,morphine hydrochloride 60 mg oral tablet,N02AA01,Morphine,Cancelled post market,2014-07-30
12702,Human,00869325,Morphine Extra-Forte,Pfizer Canada Ulc,,,1,CCDD_NTP,9000365,morphine sulfate 50 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2020-01-06
12702,Human,00869325,Morphine Extra-Forte,Pfizer Canada Ulc,,,1,CCDD_NTP,9006219,morphine sulfate 50 mg per mL solution for injection 20 mL vial,N02AA01,Morphine,Cancelled post market,2020-01-06
12702,Human,00869325,Morphine Extra-Forte,Pfizer Canada Ulc,,,1,CCDD_NTP,9006214,morphine sulfate 50 mg per mL solution for injection 50 mL vial,N02AA01,Morphine,Cancelled post market,2020-01-06
12701,Human,00869317,Morphine Forte,Pfizer Canada Ulc,,,1,CCDD_NTP,9000362,morphine sulfate 100 mg per 4 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2019-03-04
12701,Human,00869317,Morphine Forte,Pfizer Canada Ulc,,,1,CCDD_NTP,9000364,morphine sulfate 25 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2019-03-04
6690,Human,00676411,Morphine Hp 25 - 25Mg/Ml,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000362,morphine sulfate 100 mg per 4 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2023-07-28
6690,Human,00676411,Morphine Hp 25 - 25Mg/Ml,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000364,morphine sulfate 25 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2023-07-28
7421,Human,00617288,Morphine Hp 50,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006211,morphine sulfate 250 mg per 5 mL solution for injection vial,N02AA01,Morphine,Marketed,2005-08-05
7421,Human,00617288,Morphine Hp 50,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006212,morphine sulfate 500 mg per 10 mL solution for injection vial,N02AA01,Morphine,Marketed,2005-08-05
7421,Human,00617288,Morphine Hp 50,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006213,morphine sulfate 50 mg per 1 mL solution for injection vial,N02AA01,Morphine,Marketed,2005-08-05
7421,Human,00617288,Morphine Hp 50,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006214,morphine sulfate 50 mg per mL solution for injection 50 mL vial,N02AA01,Morphine,Marketed,2005-08-05
13966,Human,02021056,Morphine Lp Epidural,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000432,morphine sulfate 5 mg per 10 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2005-08-12
14020,Human,02021048,Morphine Lp Epidural,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000433,morphine sulfate 5 mg per 5 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2005-08-12
83602,Human,02350815,Morphine Sr,Sanis Health Inc,,,1,CCDD_NTP,9000477,morphine sulfate 15 mg prolonged-release oral tablet,N02AA01,Morphine,Cancelled post market,2020-12-23
83608,Human,02350890,Morphine Sr,Sanis Health Inc,,,1,CCDD_NTP,9000480,morphine sulfate 30 mg prolonged-release oral tablet,N02AA01,Morphine,Cancelled post market,2021-03-16
83610,Human,02350912,Morphine Sr,Sanis Health Inc,,,1,CCDD_NTP,9000482,morphine sulfate 60 mg prolonged-release oral tablet,N02AA01,Morphine,Cancelled post market,2021-06-22
83611,Human,02350920,Morphine Sr,Sanis Health Inc,,,1,BC_MOH,,morphine sulfate 100 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2014-08-01
83613,Human,02350947,Morphine Sr,Sanis Health Inc,,,1,BC_MOH,,morphine sulfate 200 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2014-08-01
3043,Human,00392588,Morphine Sulfate Inj 10Mg/Ml Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2005-08-09
3042,Human,00392561,Morphine Sulfate Inj 15Mg/Ml Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000111,morphine sulfate 15 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2005-08-09
13077,Human,01980696,Morphine Sulfate Inj 1Mg/Ml Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006225,morphine sulfate 10 mg per 10 mL solution for injection vial,N02AA01,Morphine,Cancelled post market,2021-04-21
13077,Human,01980696,Morphine Sulfate Inj 1Mg/Ml Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006226,morphine sulfate 1 mg per mL solution for injection 50 mL vial,N02AA01,Morphine,Cancelled post market,2021-04-21
13077,Human,01980696,Morphine Sulfate Inj 1Mg/Ml Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006229,morphine sulfate 5 mg per 5 mL solution for injection vial,N02AA01,Morphine,Cancelled post market,2021-04-21
13078,Human,01964437,Morphine Sulfate Inj 2Mg/Ml Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006227,morphine sulfate 2 mg per 1 mL solution for injection vial,N02AA01,Morphine,Cancelled post market,2021-04-21
13078,Human,01964437,Morphine Sulfate Inj 2Mg/Ml Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006228,morphine sulfate 2 mg per mL solution for injection 50 mL vial,N02AA01,Morphine,Cancelled post market,2021-04-21
13079,Human,01964429,Morphine Sulfate Inj 5Mg/Ml Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006230,morphine sulfate 5 mg per mL solution for injection 30 mL vial,N02AA01,Morphine,Cancelled post market,2021-04-21
99036,Human,02500701,Morphine Sulfate Injection,Jamp Pharma Corporation,,,1,CCDD_NTP,9000331,morphine sulfate 2 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2021-04-29
99037,Human,02500728,Morphine Sulfate Injection,Jamp Pharma Corporation,,,1,CCDD_NTP,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2021-04-29
99038,Human,02500736,Morphine Sulfate Injection,Jamp Pharma Corporation,,,1,CCDD_NTP,9000111,morphine sulfate 15 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2021-04-29
106420,Human,02561212,Morphine Sulfate Injection,Juno Pharma Canada Inc.,,,1,BC_MOH,,morphine sulfate 10 mg / mL solution for injection,N02AA01,Morphine,Approved,2025-09-17
106421,Human,02561220,Morphine Sulfate Injection,Juno Pharma Canada Inc.,,,1,BC_MOH,,morphine sulfate 15 mg / mL solution for injection,N02AA01,Morphine,Approved,2025-09-17
96526,Human,02474980,Morphine Sulfate Injection Bp,Sterimax Inc,,,1,CCDD_NTP,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2018-09-21
96527,Human,02474999,Morphine Sulfate Injection Bp,Sterimax Inc,,,1,BC_MOH,,morphine sulfate 15 mg / mL solution for injection,N02AA01,Morphine,Approved,2018-04-20
98805,Human,02498278,Morphine Sulfate Injection Epidural,Sterimax Inc,,,1,CCDD_NTP,9014552,morphine sulfate 5 mg per 10 mL solution for injection vial,N02AA01,Morphine,Marketed,2021-05-21
98806,Human,02498286,Morphine Sulfate Injection Epidural,Sterimax Inc,,,1,CCDD_NTP,9006229,morphine sulfate 5 mg per 5 mL solution for injection vial,N02AA01,Morphine,Marketed,2021-06-02
86876,Human,02382970,Morphine Sulfate Injection Sdz,Sandoz Canada Incorporated,,,1,BC_MOH,,morphine sulfate 1 mg / mL solution for injection,N02AA01,Morphine,Cancelled pre market,2017-08-01
86877,Human,02382989,Morphine Sulfate Injection Sdz,Sandoz Canada Incorporated,,,1,BC_MOH,,morphine sulfate 2 mg / mL solution for injection,N02AA01,Morphine,Cancelled pre market,2017-08-01
86878,Human,02382997,Morphine Sulfate Injection Sdz,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2012-10-18
86878,Human,02382997,Morphine Sulfate Injection Sdz,Sandoz Canada Incorporated,,,1,CCDD_NTP,9001392,morphine sulfate 50 mg per 5 mL solution for injection ampoule,N02AA01,Morphine,Marketed,2012-10-18
86879,Human,02383004,Morphine Sulfate Injection Sdz,Sandoz Canada Incorporated,,,1,BC_MOH,,morphine sulfate 15 mg / mL solution for injection,N02AA01,Morphine,Cancelled pre market,2017-08-01
6871,Human,00636908,Morphine Sulfate Injection Usp,Icu Medical Canada Inc,,,1,CCDD_NTP,9000262,morphine sulfate 30 mg per 30 mL solution for injection vial,N02AA01,Morphine,Cancelled post market,2020-05-04
7136,Human,00649619,Morphine Sulfate Injection Usp,Icu Medical Canada Inc,,,1,CCDD_NTP,9000260,morphine sulfate 150 mg per 30 mL solution for injection vial,N02AA01,Morphine,Cancelled post market,2019-10-14
12990,Human,00850314,Morphine Sulfate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000331,morphine sulfate 2 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Cancelled pre market,2019-03-04
12991,Human,00850322,Morphine Sulfate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000299,morphine sulfate 10 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2020-01-06
12992,Human,00850330,Morphine Sulfate Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000111,morphine sulfate 15 mg per 1 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2020-01-10
66221,Human,02242484,Morphine Sulfate Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006227,morphine sulfate 2 mg per 1 mL solution for injection vial,N02AA01,Morphine,Marketed,2005-08-09
98189,Human,02491885,Morphine Sulfate Injection Usp,Sterinova Inc.,,,1,BC_MOH,,morphine sulfate 50 mg / 50 mL solution for injection,N02AA01,Morphine,Approved,2019-08-29
98194,Human,02491931,Morphine Sulfate Injection Usp,Sterinova Inc.,,,1,CCDD_NTP,9014366,morphine sulfate 100 mg per 100 mL solution for injection bag,N02AA01,Morphine,Marketed,2020-08-25
97311,Human,02482681,"Morphine Sulfate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9006227,morphine sulfate 2 mg per 1 mL solution for injection vial,N02AA01,Morphine,Marketed,2019-12-17
97312,Human,02482703,"Morphine Sulfate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,BC_MOH,,morphine sulfate 4 mg / 1 mL solution for injection,N02AA01,Morphine,Cancelled pre market,2025-12-17
97313,Human,02482711,"Morphine Sulfate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,BC_MOH,,morphine sulfate 5 mg / 1 mL solution for injection,N02AA01,Morphine,Cancelled pre market,2025-12-17
97314,Human,02482738,"Morphine Sulfate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,BC_MOH,,morphine sulfate 8 mg / 1 mL solution for injection,N02AA01,Morphine,Cancelled pre market,2024-08-28
97315,Human,02482746,"Morphine Sulfate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9014225,morphine sulfate 10 mg per 1 mL solution for injection vial,N02AA01,Morphine,Marketed,2019-12-17
97871,Human,02488620,"Morphine Sulfate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,BC_MOH,,morphine sulfate 2 mg / 1 mL solution for injection,N02AA01,Morphine,Approved,2019-05-15
97872,Human,02488639,"Morphine Sulfate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,BC_MOH,,morphine sulfate 4 mg / 1 mL solution for injection,N02AA01,Morphine,Approved,2019-05-15
97874,Human,02488647,"Morphine Sulfate Injection, Usp",Fresenius Kabi Canada Ltd,,,1,BC_MOH,,morphine sulfate 10 mg / 1 mL solution for injection,N02AA01,Morphine,Approved,2019-05-15
14472,Human,00885509,Morphine Sulphate Inj 1Mg/Ml Bp,David Bull Laboratories (Canada) Inc.,,,1,BC_MOH,,morphine sulfate 1 mg / mL liquid for injection,N02AA01,Morphine,Cancelled post market,1998-08-13
31285,Human,02137232,Morphine Sulphate Injection 1Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9006226,morphine sulfate 1 mg per mL solution for injection 50 mL vial,N02AA01,Morphine,Cancelled post market,2020-01-06
31285,Human,02137232,Morphine Sulphate Injection 1Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9006229,morphine sulfate 5 mg per 5 mL solution for injection vial,N02AA01,Morphine,Cancelled post market,2020-01-06
31286,Human,02137240,Morphine Sulphate Injection 2Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9006228,morphine sulfate 2 mg per mL solution for injection 50 mL vial,N02AA01,Morphine,Cancelled post market,2018-11-30
31288,Human,02137267,Morphine Sulphate Injection 50Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9006214,morphine sulfate 50 mg per mL solution for injection 50 mL vial,N02AA01,Morphine,Cancelled post market,2018-11-30
15941,Human,02022672,Morphine Sulphate Injection B.P. 25Mg/Ml,David Bull Laboratories (Canada) Inc.,,,1,BC_MOH,,morphine sulfate 25 mg / mL liquid for injection,N02AA01,Morphine,Cancelled post market,1997-08-14
17139,Human,02022680,Morphine Sulphate Injection B.P. 50Mg/Ml,David Bull Laboratories (Canada) Inc.,,,1,BC_MOH,,morphine sulfate 50 mg / mL liquid for injection,N02AA01,Morphine,Cancelled post market,1998-08-13
14524,Human,02003759,Morphine Sulphate Injection Bp 2Mg/Ml,David Bull Laboratories (Canada) Inc.,,,1,BC_MOH,,morphine sulfate 2 mg / mL liquid for injection,N02AA01,Morphine,Cancelled post market,1998-08-13
13913,Human,02010380,"Morphine Sulphate Injection, Usp",International Medication Systems Ltd.,,,1,BC_MOH,,morphine sulfate 25 mg / mL liquid for injection,N02AA01,Morphine,Cancelled post market,1997-08-15
13905,Human,02009897,"Morphine Sulphate Injection, Usp Liq50Mg/Ml",International Medication Systems Ltd.,,,1,BC_MOH,,morphine sulfate 50 mg / mL liquid for injection,N02AA01,Morphine,Cancelled post market,1997-08-15
14099,Human,02010364,"Morphine Sulphate Injection,Usp Liq 1.1Mg/Ml",International Medication Systems Ltd.,,,1,BC_MOH,,morphine sulfate 1.1 mg / mL liquid for injection,N02AA01,Morphine,Cancelled post market,1997-08-15
12728,Human,01949055,Morphine-Epd,Pfizer Canada Ulc,,,1,CCDD_NTP,9000433,morphine sulfate 5 mg per 5 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2019-03-04
12968,Human,01949047,Morphine-Epd,Pfizer Canada Ulc,,,1,CCDD_NTP,9000432,morphine sulfate 5 mg per 10 mL solution for injection ampoule,N02AA01,Morphine,Cancelled post market,2020-01-06
14142,Human,02014327,Ms Contin,Purdue Pharma,,,1,CCDD_NTP,9000478,morphine sulfate 200 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,1993-12-31
14176,Human,02014297,Ms Contin,Purdue Pharma,,,1,CCDD_NTP,9000480,morphine sulfate 30 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,1993-12-31
14178,Human,02014319,Ms Contin,Purdue Pharma,,,1,CCDD_NTP,9000475,morphine sulfate 100 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,1993-12-31
14394,Human,02014300,Ms Contin,Purdue Pharma,,,1,CCDD_NTP,9000482,morphine sulfate 60 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,1993-12-31
14395,Human,02015439,Ms Contin,Purdue Pharma,,,1,CCDD_NTP,9000477,morphine sulfate 15 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,1993-12-31
18562,Human,02145952,Ms Contin Suppositories - 100Mg,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 100 mg / suppository rectal sustained-release suppository,N02AA01,Morphine,Cancelled post market,2003-07-29
18561,Human,02145960,Ms Contin Suppositories - 200Mg,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 200 mg / suppository rectal sustained-release suppository,N02AA01,Morphine,Cancelled post market,2003-07-29
18557,Human,02146827,Ms Contin Suppositories - 30Mg,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 30 mg / suppository rectal sustained-release suppository,N02AA01,Morphine,Cancelled post market,2003-07-29
18563,Human,02145944,Ms Contin Suppositories - 60Mg,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 60 mg / suppository rectal sustained-release suppository,N02AA01,Morphine,Cancelled post market,2003-07-29
47228,Human,02229420,Ms Contin Tablets,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 5 mg / tablet oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2017-07-27
66655,Human,02242827,Ms Contin Xl Capsules,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 30 mg / sustained‑release capsule oral prolonged-release capsule,N02AA01,Morphine,Cancelled pre market,2017-07-27
66656,Human,02242828,Ms Contin Xl Capsules,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 60 mg / sustained‑release capsule oral prolonged-release capsule,N02AA01,Morphine,Cancelled pre market,2017-07-27
66657,Human,02242829,Ms Contin Xl Capsules,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 90 mg / sustained‑release capsule oral prolonged-release capsule,N02AA01,Morphine,Cancelled pre market,2017-07-27
66658,Human,02242830,Ms Contin Xl Capsules,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 120 mg / sustained‑release capsule oral prolonged-release capsule,N02AA01,Morphine,Cancelled pre market,2017-07-27
66659,Human,02242831,Ms Contin Xl Capsules,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 150 mg / sustained‑release capsule oral prolonged-release capsule,N02AA01,Morphine,Cancelled pre market,2017-07-27
66660,Human,02242832,Ms Contin Xl Capsules,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 200 mg / sustained‑release capsule oral prolonged-release capsule,N02AA01,Morphine,Cancelled pre market,2017-07-27
15728,Human,02014246,Ms Ir Sup 10Mg,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 10 mg / suppository rectal suppository,N02AA01,Morphine,Cancelled post market,2003-07-29
15729,Human,02014262,Ms Ir Sup 20Mg,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 20 mg / suppository rectal suppository,N02AA01,Morphine,Cancelled post market,2003-07-29
15727,Human,02014173,Ms Ir Sup 30Mg,Purdue Pharma,,,1,BC_MOH,,morphine sulfate 30 mg / suppository rectal suppository,N02AA01,Morphine,Cancelled post market,2003-07-29
14144,Human,02014211,Ms.Ir,Purdue Pharma,,,1,CCDD_NTP,9000229,morphine sulfate 10 mg oral tablet,N02AA01,Morphine,Marketed,1993-12-31
16102,Human,02014203,Ms.Ir,Purdue Pharma,,,1,CCDD_NTP,9000233,morphine sulfate 5 mg oral tablet,N02AA01,Morphine,Marketed,1991-12-31
16480,Human,02014238,Ms.Ir,Purdue Pharma,,,1,CCDD_NTP,9000389,morphine sulfate 20 mg oral tablet,N02AA01,Morphine,Marketed,1991-12-31
16481,Human,02014254,Ms.Ir,Purdue Pharma,,,1,CCDD_NTP,9000390,morphine sulfate 30 mg oral tablet,N02AA01,Morphine,Marketed,1991-12-31
83180,Human,02346362,Ntp-Morphine Sr,Teva Canada Limited,,,1,BC_MOH,,morphine sulfate 15 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2015-08-06
83181,Human,02346370,Ntp-Morphine Sr,Teva Canada Limited,,,1,BC_MOH,,morphine sulfate 30 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2015-08-06
83182,Human,02346389,Ntp-Morphine Sr,Teva Canada Limited,,,1,BC_MOH,,morphine sulfate 60 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2015-08-06
83183,Human,02346397,Ntp-Morphine Sr,Teva Canada Limited,,,1,BC_MOH,,morphine sulfate 100 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2015-08-06
83184,Human,02346400,Ntp-Morphine Sr,Teva Canada Limited,,,1,BC_MOH,,morphine sulfate 200 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled pre market,2015-08-06
146,Human,00094277,Opium Tincture,D.C. Labs Limited,,,1,BC_MOH,,morphine (opium) 10 mg / mL oral tincture,N02AA01,Morphine,Cancelled post market,2003-07-11
13251,Human,01988743,Oramorph Sr Tablets 100Mg,"Roxane Labs, Division Of Boehringer Ingelheim",,,1,BC_MOH,,morphine sulfate 100 mg / tablet oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2001-07-30
13250,Human,01988727,Oramorph Sr Tablets 30Mg,"Roxane Labs, Division Of Boehringer Ingelheim",,,1,BC_MOH,,morphine sulfate 30 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2002-07-25
13242,Human,01988735,Oramorph Sr Tablets 60Mg,"Roxane Labs, Division Of Boehringer Ingelheim",,,1,BC_MOH,,morphine sulfate 60 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2002-07-25
103861,Human,02549794,Pms-Morphine Sulfate,Pharmascience Inc,,,1,CCDD_NTP,9000233,morphine sulfate 5 mg oral tablet,N02AA01,Morphine,Marketed,2024-07-29
103862,Human,02549808,Pms-Morphine Sulfate,Pharmascience Inc,,,1,CCDD_NTP,9000229,morphine sulfate 10 mg oral tablet,N02AA01,Morphine,Marketed,2024-07-29
103863,Human,02549816,Pms-Morphine Sulfate,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 25 mg oral tablet,N02AA01,Morphine,Approved,2024-07-09
103864,Human,02549824,Pms-Morphine Sulfate,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 50 mg oral tablet,N02AA01,Morphine,Approved,2024-07-09
103856,Human,02549743,Pms-Morphine Sulfate Ir,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 5 mg oral immediate release tablet,N02AA01,Morphine,Approved,2024-07-09
103857,Human,02549751,Pms-Morphine Sulfate Ir,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 10 mg oral immediate release tablet,N02AA01,Morphine,Approved,2024-07-09
103858,Human,02549778,Pms-Morphine Sulfate Ir,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 20 mg oral immediate release tablet,N02AA01,Morphine,Approved,2024-07-09
103859,Human,02549786,Pms-Morphine Sulfate Ir,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 30 mg oral immediate release tablet,N02AA01,Morphine,Approved,2024-07-09
69311,Human,02245287,Pms-Morphine Sulfate Sr 100 Mg,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 100 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2012-11-09
69308,Human,02245284,Pms-Morphine Sulfate Sr 15 Mg,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 15 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2012-11-09
69312,Human,02245288,Pms-Morphine Sulfate Sr 200 Mg,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 200 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2012-11-09
69309,Human,02245285,Pms-Morphine Sulfate Sr 30 Mg,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 30 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2012-11-09
69310,Human,02245286,Pms-Morphine Sulfate Sr 60 Mg,Pharmascience Inc,,,1,BC_MOH,,morphine sulfate 60 mg oral prolonged-release tablet,N02AA01,Morphine,Cancelled post market,2012-11-09
6539,Human,00607762,Ratio-Morphine,Teva Canada Limited,,,1,CCDD_NTP,9000209,morphine hydrochloride 1 mg per mL syrup,N02AA01,Morphine,Cancelled post market,2018-05-18
6540,Human,00607770,Ratio-Morphine,Teva Canada Limited,,,1,CCDD_NTP,9000228,morphine hydrochloride 5 mg per mL syrup,N02AA01,Morphine,Cancelled post market,2018-05-18
6903,Human,00690791,Ratio-Morphine,Teva Canada Limited,,,1,CCDD_NTP,9000259,morphine hydrochloride 20 mg per mL syrup,N02AA01,Morphine,Cancelled post market,2018-05-18
7123,Human,00690783,Ratio-Morphine,Teva Canada Limited,,,1,CCDD_NTP,9000258,morphine hydrochloride 10 mg per mL syrup,N02AA01,Morphine,Cancelled post market,2018-05-18
68780,Human,02244790,Sandoz Morphine Sr,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000477,morphine sulfate 15 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2010-12-11
68781,Human,02244791,Sandoz Morphine Sr,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000480,morphine sulfate 30 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2010-12-11
68782,Human,02244792,Sandoz Morphine Sr,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000482,morphine sulfate 60 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2010-12-11
96959,Human,02478889,Sandoz Morphine Sr,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000475,morphine sulfate 100 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2018-12-19
96961,Human,02478897,Sandoz Morphine Sr,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000478,morphine sulfate 200 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2018-12-19
6754,Human,00594644,Statex,Endo Operations Ltd.,,,1,CCDD_NTP,9000229,morphine sulfate 10 mg oral tablet,N02AA01,Morphine,Marketed,2025-05-07
6755,Human,00594652,Statex,Endo Operations Ltd.,,,1,CCDD_NTP,9000233,morphine sulfate 5 mg oral tablet,N02AA01,Morphine,Marketed,2025-05-07
10485,Human,00705799,Statex Dps 50Mg/Ml,Paladin Pharma Inc.,,,1,CCDD_NTP,9000264,morphine sulfate 50 mg per mL oral drops,N02AA01,Morphine,Cancelled post market,2018-12-07
6131,Human,00621935,Statex Drops 20Mg/Ml,Paladin Pharma Inc.,,,1,CCDD_NTP,9000211,morphine sulfate 20 mg per mL oral drops,N02AA01,Morphine,Cancelled post market,2018-09-18
6129,Human,00596965,Statex Suppositories 20Mg,Paladin Pharma Inc.,,,1,CCDD_NTP,9000231,morphine sulfate 20 mg suppository,N02AA01,Morphine,Cancelled post market,2021-12-23
51392,Human,00639389,Statex Suppositories 30Mg,Paladin Pharma Inc.,,,1,CCDD_NTP,9000739,morphine sulfate 30 mg suppository,N02AA01,Morphine,Cancelled post market,2022-02-10
51391,Human,00632228,Statex Suppositories 5Mg,Paladin Pharma Inc.,,,1,CCDD_NTP,9000740,morphine sulfate 5 mg suppository,N02AA01,Morphine,Cancelled post market,2021-03-05
8917,Human,00647217,Statex Syrup 10Mg/Ml,Paladin Pharma Inc.,,,1,CCDD_NTP,9000280,morphine sulfate 10 mg per mL syrup,N02AA01,Morphine,Cancelled post market,2018-09-18
6134,Human,00591467,Statex Syrup 1Mg/Ml,Paladin Pharma Inc.,,,1,CCDD_NTP,9000210,morphine sulfate 1 mg per mL syrup,N02AA01,Morphine,Cancelled post market,2019-05-31
6133,Human,00591475,Statex Syrup 5Mg/Ml,Paladin Pharma Inc.,,,1,CCDD_NTP,9000212,morphine sulfate 5 mg per mL syrup,N02AA01,Morphine,Cancelled post market,2018-09-18
6753,Human,00594636,Statex Tablet 25Mg,Paladin Pharma Inc.,,,1,CCDD_NTP,9000232,morphine sulfate 25 mg oral tablet,N02AA01,Morphine,Cancelled post market,2023-02-20
6757,Human,00675962,Statex Tablets 50Mg,Paladin Pharma Inc.,,,1,CCDD_NTP,9000263,morphine sulfate 50 mg oral tablet,N02AA01,Morphine,Cancelled post market,2023-02-20
6132,Human,00632201,Statex-Suppositories 10Mg,Paladin Pharma Inc.,,,1,CCDD_NTP,9000230,morphine sulfate 10 mg suppository,N02AA01,Morphine,Cancelled post market,2021-01-07
78808,Human,02302764,Teva-Morphine Sr,Teva Canada Limited,,,1,CCDD_NTP,9000477,morphine sulfate 15 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2011-06-03
78809,Human,02302772,Teva-Morphine Sr,Teva Canada Limited,,,1,CCDD_NTP,9000480,morphine sulfate 30 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2011-06-03
78810,Human,02302780,Teva-Morphine Sr,Teva Canada Limited,,,1,CCDD_NTP,9000482,morphine sulfate 60 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2011-06-03
78811,Human,02302799,Teva-Morphine Sr,Teva Canada Limited,,,1,CCDD_NTP,9000475,morphine sulfate 100 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2011-06-03
78812,Human,02302802,Teva-Morphine Sr,Teva Canada Limited,,,1,CCDD_NTP,9000478,morphine sulfate 200 mg prolonged-release oral tablet,N02AA01,Morphine,Marketed,2011-06-03
73910,Human,02254182,Zomorph,Ethypharm Inc,,,1,BC_MOH,,morphine sulfate 20 mg oral prolonged-release capsule,N02AA01,Morphine,Approved,2005-07-05
73911,Human,02254190,Zomorph,Ethypharm Inc,,,1,BC_MOH,,morphine sulfate 40 mg oral prolonged-release capsule,N02AA01,Morphine,Approved,2005-07-05
73912,Human,02254204,Zomorph,Ethypharm Inc,,,1,BC_MOH,,morphine sulfate 60 mg oral prolonged-release capsule,N02AA01,Morphine,Approved,2005-07-05
73913,Human,02254212,Zomorph,Ethypharm Inc,,,1,BC_MOH,,morphine sulfate 120 mg oral prolonged-release capsule,N02AA01,Morphine,Approved,2005-07-05
73914,Human,02254220,Zomorph,Ethypharm Inc,,,1,BC_MOH,,morphine sulfate 200 mg oral prolonged-release capsule,N02AA01,Morphine,Approved,2005-07-05
84905,Human,02364115,Apo-Hydromorphone,Apotex Inc,,,1,CCDD_NTP,9000253,hydromorphone hydrochloride 1 mg oral tablet,N02AA03,Hydromorphone,Marketed,2012-12-18
84906,Human,02364123,Apo-Hydromorphone,Apotex Inc,,,1,CCDD_NTP,9000202,hydromorphone hydrochloride 2 mg oral tablet,N02AA03,Hydromorphone,Marketed,2012-12-18
84907,Human,02364131,Apo-Hydromorphone,Apotex Inc,,,1,CCDD_NTP,9000204,hydromorphone hydrochloride 4 mg oral tablet,N02AA03,Hydromorphone,Marketed,2012-12-18
84908,Human,02364158,Apo-Hydromorphone,Apotex Inc,,1,1,CCDD_NTP,9000328,hydromorphone hydrochloride 8 mg oral tablet,N02AA03,Hydromorphone,Marketed,2012-12-18
96746,Human,02476614,Apo-Hydromorphone Cr,Apotex Inc,,,1,CCDD_NTP,9000583,hydromorphone hydrochloride 3 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Dormant,2020-02-08
96747,Human,02476622,Apo-Hydromorphone Cr,Apotex Inc,,,1,CCDD_NTP,9001340,hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Dormant,2021-01-29
96748,Human,02476630,Apo-Hydromorphone Cr,Apotex Inc,,,1,CCDD_NTP,9000586,hydromorphone hydrochloride 6 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Dormant,2020-01-05
96749,Human,02476649,Apo-Hydromorphone Cr,Apotex Inc,,,1,CCDD_NTP,9001341,hydromorphone hydrochloride 9 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Dormant,2019-12-12
96750,Human,02476657,Apo-Hydromorphone Cr,Apotex Inc,,,1,CCDD_NTP,9000679,hydromorphone hydrochloride 12 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Dormant,2020-08-02
96751,Human,02476665,Apo-Hydromorphone Cr,Apotex Inc,,,1,CCDD_NTP,9000948,hydromorphone hydrochloride 18 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Dormant,2021-01-11
96752,Human,02476673,Apo-Hydromorphone Cr,Apotex Inc,,,1,CCDD_NTP,9000680,hydromorphone hydrochloride 24 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Dormant,2020-10-04
96753,Human,02476681,Apo-Hydromorphone Cr,Apotex Inc,,,1,CCDD_NTP,9000781,hydromorphone hydrochloride 30 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Dormant,2021-01-08
94826,Human,02460777,Bar-Hydromorphone Cr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,hydromorphone hydrochloride 3 mg oral prolonged-release capsule,N02AA03,Hydromorphone,Cancelled pre market,2024-04-08
94827,Human,02460785,Bar-Hydromorphone Cr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,hydromorphone hydrochloride 4.5 mg oral prolonged-release capsule,N02AA03,Hydromorphone,Cancelled pre market,2024-04-08
94828,Human,02460793,Bar-Hydromorphone Cr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,hydromorphone hydrochloride 6 mg oral prolonged-release capsule,N02AA03,Hydromorphone,Cancelled pre market,2024-04-08
94829,Human,02460807,Bar-Hydromorphone Cr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,hydromorphone hydrochloride 9 mg oral prolonged-release capsule,N02AA03,Hydromorphone,Cancelled pre market,2024-04-08
94830,Human,02460815,Bar-Hydromorphone Cr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,hydromorphone hydrochloride 12 mg oral prolonged-release capsule,N02AA03,Hydromorphone,Cancelled pre market,2024-04-08
94831,Human,02460823,Bar-Hydromorphone Cr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,hydromorphone hydrochloride 18 mg oral prolonged-release capsule,N02AA03,Hydromorphone,Cancelled pre market,2024-04-08
94832,Human,02460831,Bar-Hydromorphone Cr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,hydromorphone hydrochloride 24 mg oral prolonged-release capsule,N02AA03,Hydromorphone,Cancelled pre market,2024-04-08
94833,Human,02460858,Bar-Hydromorphone Cr,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,hydromorphone hydrochloride 30 mg oral prolonged-release capsule,N02AA03,Hydromorphone,Cancelled pre market,2024-04-08
5937,Human,00627100,Dilaudid,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 2 mg / mL liquid for injection,N02AA03,Hydromorphone,Cancelled post market,2023-12-05
5938,Human,00125105,Dilaudid,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 3 mg rectal suppository,N02AA03,Hydromorphone,Cancelled post market,2010-08-05
5939,Human,00125083,Dilaudid,Purdue Pharma,,,1,CCDD_NTP,9000202,hydromorphone hydrochloride 2 mg oral tablet,N02AA03,Hydromorphone,Marketed,2009-01-21
5940,Human,00125121,Dilaudid,Purdue Pharma,,,1,CCDD_NTP,9000204,hydromorphone hydrochloride 4 mg oral tablet,N02AA03,Hydromorphone,Marketed,2008-12-29
6889,Human,00705438,Dilaudid,Purdue Pharma,,,1,CCDD_NTP,9000253,hydromorphone hydrochloride 1 mg oral tablet,N02AA03,Hydromorphone,Marketed,2008-12-12
9509,Human,00786543,Dilaudid,Purdue Pharma,,1,1,CCDD_NTP,9000328,hydromorphone hydrochloride 8 mg oral tablet,N02AA03,Hydromorphone,Marketed,2008-12-29
10173,Human,00786535,Dilaudid,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 1 mg / mL oral liquid,N02AA03,Hydromorphone,Cancelled post market,2018-01-23
16679,Human,02085895,Dilaudid,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 250 mg / vial powder for solution for injection,N02AA03,Hydromorphone,Cancelled post market,2013-06-07
5936,Human,00622133,Dilaudid Hp,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 10 mg / mL liquid for injection,N02AA03,Hydromorphone,Cancelled post market,2023-12-05
17822,Human,02146118,Dilaudid-Hp-Plus,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 20 mg / mL solution for injection,N02AA03,Hydromorphone,Cancelled post market,2012-08-02
17823,Human,02145863,Dilaudid-Xp,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 50 mg / mL liquid for injection,N02AA03,Hydromorphone,Cancelled post market,2012-08-02
84452,Human,02359502,Hydromorph Contin,Purdue Pharma,,,1,CCDD_NTP,9001340,hydromorphone hydrochloride 4.5 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Marketed,2011-04-14
84453,Human,02359510,Hydromorph Contin,Purdue Pharma,,,1,CCDD_NTP,9001341,hydromorphone hydrochloride 9 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Marketed,2011-04-14
20171,Human,02125366,Hydromorph Contin-Controlled Release Cap - 12Mg,Purdue Pharma,,,1,CCDD_NTP,9000679,hydromorphone hydrochloride 12 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Marketed,1996-12-31
67480,Human,02243562,Hydromorph Contin-Controlled Release Cap - 18Mg,Purdue Pharma,,,1,CCDD_NTP,9000948,hydromorphone hydrochloride 18 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Marketed,2001-07-03
20172,Human,02125382,Hydromorph Contin-Controlled Release Cap - 24Mg,Purdue Pharma,,,1,CCDD_NTP,9000680,hydromorphone hydrochloride 24 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Marketed,1996-12-31
43838,Human,02125390,Hydromorph Contin-Controlled Release Cap - 30Mg,Purdue Pharma,,,1,CCDD_NTP,9000781,hydromorphone hydrochloride 30 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Marketed,1998-02-16
18556,Human,02125323,Hydromorph Contin-Controlled Release Cap - 3Mg,Purdue Pharma,,,1,CCDD_NTP,9000583,hydromorphone hydrochloride 3 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Marketed,1995-12-31
18558,Human,02125331,Hydromorph Contin-Controlled Release Cap - 6Mg,Purdue Pharma,,,1,CCDD_NTP,9000586,hydromorphone hydrochloride 6 mg prolonged-release oral capsule,N02AA03,Hydromorphone,Marketed,1995-12-31
69806,Human,02245703,Hydromorph.Ir - 2Mg,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 2 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2012-08-02
69807,Human,02245704,Hydromorph.Ir - 4Mg,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 4 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2012-08-02
69808,Human,02245705,Hydromorph.Ir - 8Mg,Purdue Pharma,,1,1,BC_MOH,,hydromorphone hydrochloride 8 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2012-08-02
35655,Human,02192101,Hydromorphone,Sorres Pharma Inc,,,1,BC_MOH,,hydromorphone hydrochloride 1 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2014-06-20
35658,Human,02192144,Hydromorphone,Sorres Pharma Inc,,1,1,BC_MOH,,hydromorphone hydrochloride 8 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2014-06-20
73474,Human,02249928,Hydromorphone,Sorres Pharma Inc,,,1,BC_MOH,,hydromorphone hydrochloride 2 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2014-06-20
73475,Human,02249936,Hydromorphone,Sorres Pharma Inc,,,1,BC_MOH,,hydromorphone hydrochloride 4 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2014-06-20
12596,Human,01916289,Hydromorphone Hcl Tab 2Mg Usp,"Roxane Labs, Division Of Boehringer Ingelheim",,,1,BC_MOH,,hydromorphone hydrochloride 2 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2001-07-30
12595,Human,01916270,Hydromorphone Hcl Tab 4Mg Usp,"Roxane Labs, Division Of Boehringer Ingelheim",,,1,BC_MOH,,hydromorphone hydrochloride 4 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2001-07-30
18323,Human,02145928,Hydromorphone Hp 10,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000579,hydromorphone hydrochloride 100 mg per 10 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18323,Human,02145928,Hydromorphone Hp 10,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000201,hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18323,Human,02145928,Hydromorphone Hp 10,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006204,hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18323,Human,02145928,Hydromorphone Hp 10,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000206,hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18325,Human,02145936,Hydromorphone Hp 20,Sandoz Canada Incorporated,,,1,CCDD_NTP,9012635,hydromorphone hydrochloride 20 mg per mL solution for injection 50 mL vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18325,Human,02145936,Hydromorphone Hp 20,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006243,hydromorphone hydrochloride 100 mg per 5 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18325,Human,02145936,Hydromorphone Hp 20,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006244,hydromorphone hydrochloride 20 mg per 1 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18324,Human,02146126,Hydromorphone Hp 50,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000582,hydromorphone hydrochloride 250 mg per 5 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18324,Human,02146126,Hydromorphone Hp 50,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000584,hydromorphone hydrochloride 500 mg per 10 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18324,Human,02146126,Hydromorphone Hp 50,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000585,hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2005-08-26
18324,Human,02146126,Hydromorphone Hp 50,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006245,hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial,N02AA03,Hydromorphone,Marketed,2005-08-26
68787,Human,02244797,Hydromorphone Hp Forte Injection,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000966,hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial,N02AA03,Hydromorphone,Cancelled post market,2025-07-31
94803,Human,02460602,Hydromorphone Hydrochloride Injection,Sterimax Inc,,,1,CCDD_NTP,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,N02AA03,Hydromorphone,Marketed,2017-02-06
102608,Human,02537362,Hydromorphone Hydrochloride Injection,Sterimax Inc,,,1,BC_MOH,,hydromorphone hydrochloride 1 mg / mL solution for injection,N02AA03,Hydromorphone,Approved,2023-05-01
94804,Human,02460610,Hydromorphone Hydrochloride Injection Hp 10,Sterimax Inc,,,1,CCDD_NTP,9001473,hydromorphone hydrochloride 100 mg per 10 mL solution for injection ampoule,N02AA03,Hydromorphone,Marketed,2017-02-06
94804,Human,02460610,Hydromorphone Hydrochloride Injection Hp 10,Sterimax Inc,,,1,CCDD_NTP,9001474,hydromorphone hydrochloride 10 mg per 1 mL solution for injection ampoule,N02AA03,Hydromorphone,Marketed,2017-02-06
95820,Human,02469413,Hydromorphone Hydrochloride Injection Hp 50,Sterimax Inc,,,1,CCDD_NTP,9006245,hydromorphone hydrochloride 50 mg per mL solution for injection 50 mL vial,N02AA03,Hydromorphone,Marketed,2018-08-21
95820,Human,02469413,Hydromorphone Hydrochloride Injection Hp 50,Sterimax Inc,,,1,CCDD_NTP,9000585,hydromorphone hydrochloride 50 mg per 1 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2018-08-21
95689,Human,02468468,Hydromorphone Hydrochloride Injection Hp Forte,Sterimax Inc,,,1,CCDD_NTP,9000966,hydromorphone hydrochloride 1000 mg per 10 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2018-06-20
18315,Human,02145901,Hydromorphone Hydrochloride Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,N02AA03,Hydromorphone,Marketed,2005-10-08
86845,Human,02382636,Hydromorphone Hydrochloride Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000201,hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial,N02AA03,Hydromorphone,Cancelled post market,2025-11-13
86845,Human,02382636,Hydromorphone Hydrochloride Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9006204,hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial,N02AA03,Hydromorphone,Cancelled post market,2025-11-13
86845,Human,02382636,Hydromorphone Hydrochloride Injection Usp,Pfizer Canada Ulc,,,1,CCDD_NTP,9000206,hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial,N02AA03,Hydromorphone,Cancelled post market,2025-11-13
97577,Human,02485532,Hydromorphone Hydrochloride Injection Usp,Sterinova Inc.,,,1,CCDD_NTP,9014172,hydromorphone hydrochloride 20 mg per 50 mL solution for injection bag,N02AA03,Hydromorphone,Marketed,2019-09-18
97578,Human,02485540,Hydromorphone Hydrochloride Injection Usp,Sterinova Inc.,,,1,CCDD_NTP,9014173,hydromorphone hydrochloride 40 mg per 100 mL solution for injection bag,N02AA03,Hydromorphone,Marketed,2019-08-28
100362,Human,02514435,Hydromorphone Hydrochloride Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9014761,hydromorphone hydrochloride 1 mg per 1 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2022-08-24
101889,Human,02529645,Hydromorphone Hydrochloride Injection Usp,Jamp Pharma Corporation,,,1,CCDD_NTP,9000203,hydromorphone hydrochloride 2 mg per 1 mL solution for injection ampoule,N02AA03,Hydromorphone,Marketed,2023-02-22
98169,Human,02491680,"Hydromorphone Hydrochloride Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9006204,hydromorphone hydrochloride 10 mg per mL solution for injection 50 mL vial,N02AA03,Hydromorphone,Marketed,2020-11-10
98169,Human,02491680,"Hydromorphone Hydrochloride Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9000201,hydromorphone hydrochloride 10 mg per 1 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2020-11-10
98169,Human,02491680,"Hydromorphone Hydrochloride Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9000206,hydromorphone hydrochloride 50 mg per 5 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2020-11-10
98170,Human,02491699,"Hydromorphone Hydrochloride Injection, Usp",Fresenius Kabi Canada Ltd,,,1,CCDD_NTP,9014412,hydromorphone hydrochloride 2 mg per 1 mL solution for injection vial,N02AA03,Hydromorphone,Marketed,2020-11-10
13113,Human,01979914,Hydromorphone Hydrochloride Sup 3Mg,Sandoz Canada Incorporated,,,1,BC_MOH,,hydromorphone hydrochloride 3 mg rectal suppository,N02AA03,Hydromorphone,Cancelled post market,2012-01-23
82286,Human,02337266,Jurnista,Janssen Inc,,,1,CCDD_NTP,9001306,hydromorphone hydrochloride 4 mg prolonged-release oral tablet,N02AA03,Hydromorphone,Cancelled post market,2018-10-31
82287,Human,02337274,Jurnista,Janssen Inc,,,1,CCDD_NTP,9001307,hydromorphone hydrochloride 8 mg prolonged-release oral tablet,N02AA03,Hydromorphone,Cancelled post market,2018-10-31
82288,Human,02337282,Jurnista,Janssen Inc,,,1,CCDD_NTP,9001304,hydromorphone hydrochloride 16 mg prolonged-release oral tablet,N02AA03,Hydromorphone,Cancelled post market,2018-10-31
82289,Human,02337290,Jurnista,Janssen Inc,,,1,CCDD_NTP,9001305,hydromorphone hydrochloride 32 mg prolonged-release oral tablet,N02AA03,Hydromorphone,Cancelled post market,2018-10-31
67034,Human,02243159,Palladone Xl - 12Mg,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 12 mg oral controlled-delivery capsule,N02AA03,Hydromorphone,Cancelled post market,2005-08-05
67035,Human,02243160,Palladone Xl - 16Mg,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 16 mg oral controlled-delivery capsule,N02AA03,Hydromorphone,Cancelled post market,2005-08-05
67036,Human,02243161,Palladone Xl - 24Mg,Purdue Pharma,,,1,BC_MOH,,hydromorphone hydrochloride 24 mg oral controlled-delivery capsule,N02AA03,Hydromorphone,Cancelled post market,2005-08-05
73473,Human,02249901,Phl-Hydromorphone,Pharmel Inc,,,1,BC_MOH,,hydromorphone hydrochloride 3 mg rectal suppository,N02AA03,Hydromorphone,Cancelled pre market,2017-09-13
35657,Human,02192136,Phl-Hydromorphone -Syr 1Mg/Ml,Pharmel Inc,,,1,BC_MOH,,hydromorphone hydrochloride 1 mg / mL oral syrup,N02AA03,Hydromorphone,Cancelled pre market,2017-09-13
11870,Human,01916386,Pms Hydromorphone Sirop 1Mg/Ml,Pharmascience Inc,,,1,CCDD_NTP,9000384,hydromorphone hydrochloride 1 mg per mL syrup,N02AA03,Hydromorphone,Marketed,1991-12-31
11869,Human,01916394,Pms Hydromorphone Suppositoire 3Mg,Pharmascience Inc,,,1,CCDD_NTP,9000385,hydromorphone hydrochloride 3 mg suppository,N02AA03,Hydromorphone,Cancelled post market,2025-07-04
11413,Human,00885444,Pms-Hydromorphone Tab 1Mg,Pharmascience Inc,,,1,CCDD_NTP,9000253,hydromorphone hydrochloride 1 mg oral tablet,N02AA03,Hydromorphone,Marketed,1991-12-31
11428,Human,00885436,Pms-Hydromorphone Tab 2Mg,Pharmascience Inc,,,1,CCDD_NTP,9000202,hydromorphone hydrochloride 2 mg oral tablet,N02AA03,Hydromorphone,Marketed,1991-12-31
11425,Human,00885401,Pms-Hydromorphone Tab 4Mg,Pharmascience Inc,,,1,CCDD_NTP,9000204,hydromorphone hydrochloride 4 mg oral tablet,N02AA03,Hydromorphone,Marketed,1991-12-31
11363,Human,00885428,Pms-Hydromorphone Tab 8Mg,Pharmascience Inc,,1,1,CCDD_NTP,9000328,hydromorphone hydrochloride 8 mg oral tablet,N02AA03,Hydromorphone,Marketed,1991-12-31
80489,Human,02319403,Teva-Hydromorphone,Teva Canada Limited,,,1,CCDD_NTP,9000253,hydromorphone hydrochloride 1 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2021-07-30
80490,Human,02319411,Teva-Hydromorphone,Teva Canada Limited,,,1,CCDD_NTP,9000202,hydromorphone hydrochloride 2 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2021-07-30
80491,Human,02319438,Teva-Hydromorphone,Teva Canada Limited,,,1,CCDD_NTP,9000204,hydromorphone hydrochloride 4 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2021-07-30
80492,Human,02319446,Teva-Hydromorphone,Teva Canada Limited,,1,1,CCDD_NTP,9000328,hydromorphone hydrochloride 8 mg oral tablet,N02AA03,Hydromorphone,Cancelled post market,2021-07-30
106455,Human,02561603,Hydromorphone Hydrochloride Injection Usp,Sterinova Inc.,,,1,BC_MOH,,hydromorphone hydrochloride 20 mg / 100 mL solution for injection,N02AA03,Hydromorphone,Approved,2025-11-07
87933,Human,02394170,Act Oxycodone Cr,Teva Canada Limited,,,1,CCDD_NTP,9001393,oxycodone hydrochloride 5 mg prolonged-release oral tablet,N02AA05,Oxycodone,Cancelled post market,2020-06-11
87934,Human,02394189,Act Oxycodone Cr,Teva Canada Limited,,,1,CCDD_NTP,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,N02AA05,Oxycodone,Cancelled post market,2020-06-11
87935,Human,02394197,Act Oxycodone Cr,Teva Canada Limited,,,1,CCDD_NTP,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,N02AA05,Oxycodone,Cancelled post market,2020-06-11
87936,Human,02394200,Act Oxycodone Cr,Teva Canada Limited,,,1,CCDD_NTP,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,N02AA05,Oxycodone,Cancelled post market,2020-06-11
87937,Human,02394219,Act Oxycodone Cr,Teva Canada Limited,,,1,CCDD_NTP,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,N02AA05,Oxycodone,Cancelled post market,2020-06-11
79224,Human,02306530,Apo-Oxycodone Cr,Apotex Inc,,,1,CCDD_NTP,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-26
85157,Human,02366746,Apo-Oxycodone Cr,Apotex Inc,,,1,CCDD_NTP,9001393,oxycodone hydrochloride 5 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-26
85158,Human,02366754,Apo-Oxycodone Cr,Apotex Inc,,,1,CCDD_NTP,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2018-05-17
85159,Human,02366762,Apo-Oxycodone Cr,Apotex Inc,,,1,CCDD_NTP,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-26
85161,Human,02366789,Apo-Oxycodone Cr,Apotex Inc,,,1,CCDD_NTP,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-26
87990,Human,02394766,Apo-Oxycodone Cr,Apotex Inc,,,1,CCDD_NTP,9001356,oxycodone hydrochloride 15 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-27
87991,Human,02394774,Apo-Oxycodone Cr,Apotex Inc,,,1,CCDD_NTP,9001358,oxycodone hydrochloride 30 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2018-06-13
87993,Human,02394782,Apo-Oxycodone Cr,Apotex Inc,,,1,CCDD_NTP,9001360,oxycodone hydrochloride 60 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-27
51386,Human,02231934,Oxy.Ir,Purdue Pharma,,,1,CCDD_NTP,9000367,oxycodone hydrochloride 5 mg oral tablet,N02AA05,Oxycodone,Marketed,2000-03-31
63645,Human,02240131,Oxy.Ir,Purdue Pharma,,,1,CCDD_NTP,9000153,oxycodone hydrochloride 10 mg oral tablet,N02AA05,Oxycodone,Marketed,2000-03-31
63646,Human,02240132,Oxy.Ir,Purdue Pharma,,,1,CCDD_NTP,9000890,oxycodone hydrochloride 20 mg oral tablet,N02AA05,Oxycodone,Marketed,2000-03-31
81130,Human,02325950,Oxycodone,Pro Doc Limitee,,,1,CCDD_NTP,9000367,oxycodone hydrochloride 5 mg oral tablet,N02AA05,Oxycodone,Cancelled post market,2019-11-01
81131,Human,02325969,Oxycodone,Pro Doc Limitee,,,1,CCDD_NTP,9000153,oxycodone hydrochloride 10 mg oral tablet,N02AA05,Oxycodone,Cancelled post market,2019-11-01
81132,Human,02325977,Oxycodone,Pro Doc Limitee,,,1,CCDD_NTP,9000890,oxycodone hydrochloride 20 mg oral tablet,N02AA05,Oxycodone,Cancelled post market,2019-11-01
80868,Human,02323192,Oxycontin,Purdue Pharma,,,1,BC_MOH,,oxycodone hydrochloride 15 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled post market,2012-09-26
80869,Human,02323206,Oxycontin,Purdue Pharma,,,1,BC_MOH,,oxycodone hydrochloride 30 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled post market,2012-09-26
80870,Human,02323214,Oxycontin,Purdue Pharma,,,1,BC_MOH,,oxycodone hydrochloride 60 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled post market,2012-09-26
20173,Human,02202441,Oxycontin 10Mg,Purdue Pharma,,,1,BC_MOH,,oxycodone hydrochloride 10 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled post market,2012-09-26
20174,Human,02202468,Oxycontin 20Mg,Purdue Pharma,,,1,BC_MOH,,oxycodone hydrochloride 20 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled post market,2012-09-26
20175,Human,02202476,Oxycontin 40Mg,Purdue Pharma,,,1,BC_MOH,,oxycodone hydrochloride 40 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled post market,2012-09-26
74336,Human,02258129,Oxycontin 5Mg,Purdue Pharma,,,1,BC_MOH,,oxycodone hydrochloride 5 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled post market,2012-09-26
20176,Human,02202484,Oxycontin 80Mg,Purdue Pharma,,,1,BC_MOH,,oxycodone hydrochloride 80 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled post market,2012-09-26
85760,Human,02372525,Oxyneo,Purdue Pharma,,,1,CCDD_NTP,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2011-09-13
85765,Human,02372533,Oxyneo,Purdue Pharma,,,1,CCDD_NTP,9001356,oxycodone hydrochloride 15 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2011-09-13
85766,Human,02372541,Oxyneo,Purdue Pharma,,,1,CCDD_NTP,9001358,oxycodone hydrochloride 30 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2011-09-13
85767,Human,02372568,Oxyneo,Purdue Pharma,,,1,CCDD_NTP,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2011-09-13
85768,Human,02372576,Oxyneo,Purdue Pharma,,,1,CCDD_NTP,9001360,oxycodone hydrochloride 60 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2011-09-13
85769,Human,02372584,Oxyneo,Purdue Pharma,,,1,CCDD_NTP,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2011-09-13
85788,Human,02372797,Oxyneo,Purdue Pharma,,,1,CCDD_NTP,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2011-09-13
80542,Human,02319977,Pms-Oxycodone,Pharmascience Inc,,,1,CCDD_NTP,9000367,oxycodone hydrochloride 5 mg oral tablet,N02AA05,Oxycodone,Marketed,2008-12-03
80543,Human,02319985,Pms-Oxycodone,Pharmascience Inc,,,1,CCDD_NTP,9000153,oxycodone hydrochloride 10 mg oral tablet,N02AA05,Oxycodone,Marketed,2008-12-03
80544,Human,02319993,Pms-Oxycodone,Pharmascience Inc,,,1,CCDD_NTP,9000890,oxycodone hydrochloride 20 mg oral tablet,N02AA05,Oxycodone,Marketed,2008-12-03
79557,Human,02309882,Pms-Oxycodone Cr,Pharmascience Inc,,,1,CCDD_NTP,9001355,oxycodone hydrochloride 10 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-27
79558,Human,02309890,Pms-Oxycodone Cr,Pharmascience Inc,,,1,CCDD_NTP,9001357,oxycodone hydrochloride 20 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-27
79559,Human,02309904,Pms-Oxycodone Cr,Pharmascience Inc,,,1,CCDD_NTP,9001359,oxycodone hydrochloride 40 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-27
79560,Human,02309912,Pms-Oxycodone Cr,Pharmascience Inc,,,1,CCDD_NTP,9001361,oxycodone hydrochloride 80 mg prolonged-release oral tablet,N02AA05,Oxycodone,Marketed,2012-11-27
88247,Human,02397536,Pms-Oxycodone Cr,Pharmascience Inc,,,1,BC_MOH,,oxycodone hydrochloride 5 mg oral prolonged-release tablet,N02AA05,Oxycodone,Approved,2012-11-26
88248,Human,02397544,Pms-Oxycodone Cr,Pharmascience Inc,,,1,BC_MOH,,oxycodone hydrochloride 15 mg oral prolonged-release tablet,N02AA05,Oxycodone,Approved,2012-11-26
88249,Human,02397552,Pms-Oxycodone Cr,Pharmascience Inc,,,1,BC_MOH,,oxycodone hydrochloride 30 mg oral prolonged-release tablet,N02AA05,Oxycodone,Approved,2012-11-26
88250,Human,02397560,Pms-Oxycodone Cr,Pharmascience Inc,,,1,BC_MOH,,oxycodone hydrochloride 60 mg oral prolonged-release tablet,N02AA05,Oxycodone,Approved,2012-11-26
90089,Human,02416336,Ran-Oxycodone Cr,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,oxycodone hydrochloride 15 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2022-05-16
90090,Human,02416344,Ran-Oxycodone Cr,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,oxycodone hydrochloride 20 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2022-05-16
90091,Human,02416352,Ran-Oxycodone Cr,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,oxycodone hydrochloride 40 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2022-05-16
90092,Human,02416360,Ran-Oxycodone Cr,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,oxycodone hydrochloride 60 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2022-05-16
90093,Human,02416379,Ran-Oxycodone Cr,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,oxycodone hydrochloride 80 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2022-05-16
82658,Human,02341034,Riva-Oxycodone Cr,Laboratoire Riva Inc.,,,1,BC_MOH,,oxycodone hydrochloride 10 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2016-10-13
82659,Human,02341042,Riva-Oxycodone Cr,Laboratoire Riva Inc.,,,1,BC_MOH,,oxycodone hydrochloride 20 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2016-10-13
82660,Human,02341050,Riva-Oxycodone Cr,Laboratoire Riva Inc.,,,1,BC_MOH,,oxycodone hydrochloride 40 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2016-10-13
82661,Human,02341069,Riva-Oxycodone Cr,Laboratoire Riva Inc.,,,1,BC_MOH,,oxycodone hydrochloride 80 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2016-10-13
81160,Human,02326264,Sandoz Oxycodone Cr,Sandoz Canada Incorporated,,,1,BC_MOH,,oxycodone hydrochloride 10 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2018-08-01
81161,Human,02326272,Sandoz Oxycodone Cr,Sandoz Canada Incorporated,,,1,BC_MOH,,oxycodone hydrochloride 20 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2018-08-03
81162,Human,02326280,Sandoz Oxycodone Cr,Sandoz Canada Incorporated,,,1,BC_MOH,,oxycodone hydrochloride 40 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2018-08-01
81163,Human,02326299,Sandoz Oxycodone Cr,Sandoz Canada Incorporated,,,1,BC_MOH,,oxycodone hydrochloride 80 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2018-08-01
88245,Human,02397501,Sandoz Oxycodone Cr,Sandoz Canada Incorporated,,,1,BC_MOH,,oxycodone hydrochloride 5 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2018-08-01
3551,Human,00392480,Supeudol 10,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000069,oxycodone hydrochloride 10 mg suppository,N02AA05,Oxycodone,Cancelled post market,2022-08-26
3996,Human,00443948,Supeudol 10,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000153,oxycodone hydrochloride 10 mg oral tablet,N02AA05,Oxycodone,Marketed,2005-08-05
3550,Human,00392472,Supeudol 20,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000070,oxycodone hydrochloride 20 mg suppository,N02AA05,Oxycodone,Cancelled post market,2022-12-06
74839,Human,02262983,Supeudol 20,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000890,oxycodone hydrochloride 20 mg oral tablet,N02AA05,Oxycodone,Marketed,2024-10-04
10433,Human,00789739,Supeudol 5,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000367,oxycodone hydrochloride 5 mg oral tablet,N02AA05,Oxycodone,Marketed,2005-08-05
77056,Human,02285037,Teva-Oxycodone Cr,Teva Canada Limited,,,1,BC_MOH,,oxycodone hydrochloride 10 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2015-10-16
77057,Human,02285045,Teva-Oxycodone Cr,Teva Canada Limited,,,1,BC_MOH,,oxycodone hydrochloride 20 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2015-10-16
77663,Human,02291266,Teva-Oxycodone Cr,Teva Canada Limited,,,1,BC_MOH,,oxycodone hydrochloride 40 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2015-10-16
77664,Human,02291274,Teva-Oxycodone Cr,Teva Canada Limited,,,1,BC_MOH,,oxycodone hydrochloride 80 mg oral prolonged-release tablet,N02AA05,Oxycodone,Cancelled pre market,2015-10-21
82520,Human,02339609,Targin,Purdue Pharma,,,2,CCDD_NTP,9001324,naloxone hydrochloride 5 mg and oxycodone hydrochloride 10 mg prolonged-release oral tablet,N02AA55,Oxycodone and naloxone,Marketed,2010-10-05
82521,Human,02339617,Targin,Purdue Pharma,,,2,CCDD_NTP,9001322,naloxone hydrochloride 10 mg and oxycodone hydrochloride 20 mg prolonged-release oral tablet,N02AA55,Oxycodone and naloxone,Marketed,2010-10-05
82522,Human,02339625,Targin,Purdue Pharma,,,2,CCDD_NTP,9001323,naloxone hydrochloride 20 mg and oxycodone hydrochloride 40 mg prolonged-release oral tablet,N02AA55,Oxycodone and naloxone,Marketed,2010-10-05
87301,Human,02387425,Targin,Purdue Pharma,,,2,CCDD_NTP,9001391,naloxone hydrochloride 2.5 mg and oxycodone hydrochloride 5 mg prolonged-release oral tablet,N02AA55,Oxycodone and naloxone,Marketed,2012-10-16
73918,Human,02254263,Phl-Acet-Codeine 60,Pharmel Inc,,,2,BC_MOH,,acetaminophen 300 mg + codeine phosphate 60 mg oral tablet,N02AA59,"Codeine, combinations excl. psycholeptics",Cancelled post market,2004-07-22
3932,Human,00477672,Rounox Codeine 60 Tab,Rougier Pharma Division Of Ratiopharm Inc,,,2,BC_MOH,,acetaminophen 325 mg / tablet + codeine phosphate 60 mg / tablet oral tablet,N02AA59,"Codeine, combinations excl. psycholeptics",Cancelled post market,1999-09-27
3029,Human,00396516,Tylenol W Codeine No4 Tab,"Mcneil Pharmaceutical, Division Of Ortho-Mcneil Inc.",,,2,BC_MOH,,acetaminophen 300 mg / tablet + codeine phosphate 60 mg / tablet oral tablet,N02AA59,"Codeine, combinations excl. psycholeptics",Cancelled post market,1996-09-09
104346,Human,02554623,Apo-Butalbital-Acetylsalicylic Acid-Caffeine-Codeine-C 1/2,Apotex Inc,,,4,CCDD_NTP,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Marketed,2025-05-08
104345,Human,02554615,Apo-Butalbital-Acetylsalicylic Acid-Caffeine-Codeine-C 1/4,Apotex Inc,,,4,CCDD_NTP,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Marketed,2025-05-08
873,Human,00176206,Fiorinal-C 1/2,Aralez Pharmaceuticals Canada Inc,,,4,CCDD_NTP,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Marketed,2018-12-10
872,Human,00176192,Fiorinal-C 1/4,Aralez Pharmaceuticals Canada Inc,,,4,CCDD_NTP,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Marketed,2020-10-21
26956,Human,02042886,Phenaphen No.4 Cap,Wyeth-Ayerst Canada Inc.,,,3,BC_MOH,,acetylsalicylic acid 325 mg / capsule + codeine phosphate 64.8 mg / capsule + phenobarbital 16.2 mg / capsule oral capsule,N02AA79,"Codein, combinations with psycholeptics",Cancelled post market,2002-05-17
52471,Human,02232986,Pms-Pharnal-C1/2 Capsules,Pharmascience Inc,,,4,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg + codeine phosphate 30 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Cancelled pre market,2017-08-03
47954,Human,02229734,Pronal - C1/2 Capsules,Pro Doc Limitee,,,4,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg + codeine phosphate 30 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Cancelled post market,2013-01-18
47955,Human,02229735,Pronal C1/4 Capsules,Pro Doc Limitee,,,4,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg + codeine phosphate 15 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Cancelled post market,2013-01-18
6419,Human,00608181,Teva-Tecnal C 1/2,Teva Canada Limited,,,4,CCDD_NTP,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Marketed,2017-11-20
6479,Human,00608203,Teva-Tecnal C 1/4,Teva Canada Limited,,,4,CCDD_NTP,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Marketed,2017-11-20
66118,Human,02242406,Trianal C¼,Laboratoire Riva Inc.,,,4,CCDD_NTP,9001651,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 15 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Dormant,2020-07-27
23669,Human,01971387,Trianal C½,Laboratoire Riva Inc.,,,4,CCDD_NTP,9001652,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg oral capsule,N02AA79,"Codein, combinations with psycholeptics",Dormant,2020-08-31
18316,Human,02138018,Demerol,Sanofi-Aventis Canada Inc,,,1,CCDD_NTP,9000001,meperidine hydrochloride 50 mg oral tablet,N02AB02,Pethidine,Cancelled post market,2020-07-02
18318,Human,02139030,Demerol 10%-Liq Im Iv Sc,"Sanofi Canada, Inc.",,,1,BC_MOH,,meperidine hydrochloride 100 mg / mL liquid for injection,N02AB02,Pethidine,Cancelled post market,2001-08-10
18317,Human,02139715,Demerol 10%-Liq Im Sc 100Mg/Ml,"Sanofi Canada, Inc.",,,1,BC_MOH,,meperidine hydrochloride 100 mg / mL liquid for injection,N02AB02,Pethidine,Cancelled post market,2001-08-17
65675,Human,02242005,Demerol 100 Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9006625,meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule,N02AB02,Pethidine,Cancelled post market,2018-10-25
65676,Human,02242006,Demerol 100 Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9006271,meperidine hydrochloride 100 mg per mL solution for injection 20 mL vial,N02AB02,Pethidine,Cancelled post market,2018-10-25
65672,Human,02242002,Demerol 50 Mg/Ml  (Multiple Dose With Metacresol As Preservative),Hospira Healthcare Ulc,,,1,BC_MOH,,meperidine hydrochloride 50 mg / mL solution for injection,N02AB02,Pethidine,Cancelled post market,2012-08-03
65673,Human,02242003,"Demerol 50 Mg/Ml  (Single Use, Preservative Free)",Hospira Healthcare Ulc,,,1,CCDD_NTP,9006548,meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule,N02AB02,Pethidine,Cancelled post market,2018-10-25
18079,Human,02139022,Demerol 50Mg - Liq Im Iv Sc 50Mg/Ml,"Sanofi Canada, Inc.",,,1,BC_MOH,,meperidine hydrochloride 50 mg / mL liquid for injection,N02AB02,Pethidine,Cancelled post market,2001-08-10
18077,Human,02137992,Demerol 50Mg - Liq Im Sc  50Mg/Ml,"Sanofi Canada, Inc.",,,1,BC_MOH,,meperidine hydrochloride 50 mg / mL liquid for injection,N02AB02,Pethidine,Cancelled post market,2001-08-10
65674,Human,02242004,Demerol 75 Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9006626,meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule,N02AB02,Pethidine,Cancelled post market,2018-10-25
18078,Human,02139049,Demerol 75Mg - Liq Im Iv Sc 75Mg/Ml,"Sanofi Canada, Inc.",,,1,BC_MOH,,meperidine hydrochloride 75 mg / mL liquid for injection,N02AB02,Pethidine,Cancelled post market,2001-08-10
4237,Human,00497479,Meperidine Hcl Injection 100Mg/Ml,Hospira Healthcare Ulc,,,1,BC_MOH,,meperidine hydrochloride 100 mg / mL solution for injection,N02AB02,Pethidine,Cancelled post market,2012-08-03
4294,Human,00497436,Meperidine Hcl Injection 10Mg/Ml,Hospira Healthcare Ulc,,,1,BC_MOH,,meperidine hydrochloride 10 mg / mL solution for injection,N02AB02,Pethidine,Cancelled post market,2012-08-03
4234,Human,00497444,Meperidine Hcl Injection 25Mg/Ml,Hospira Healthcare Ulc,,,1,BC_MOH,,meperidine hydrochloride 25 mg / mL solution for injection,N02AB02,Pethidine,Cancelled post market,2012-08-03
4235,Human,00497452,Meperidine Hcl Injection 50Mg/Ml,Hospira Healthcare Ulc,,,1,BC_MOH,,meperidine hydrochloride 50 mg / mL solution for injection,N02AB02,Pethidine,Cancelled post market,2012-08-03
4236,Human,00497460,Meperidine Hcl Injection 75Mg/Ml,Hospira Healthcare Ulc,,,1,BC_MOH,,meperidine hydrochloride 75 mg / mL solution for injection,N02AB02,Pethidine,Cancelled post market,2012-08-03
6872,Human,00640409,Meperidine Hydrochloride Injection Usp,Icu Medical Canada Inc,,,1,CCDD_NTP,9006208,meperidine hydrochloride 10 mg per mL solution for injection 30 mL vial,N02AB02,Pethidine,Cancelled post market,2018-09-28
8120,Human,00725757,Meperidine Hydrochloride Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006626,meperidine hydrochloride 75 mg per 1 mL solution for injection ampoule,N02AB02,Pethidine,Cancelled post market,2021-04-23
8121,Human,00725765,Meperidine Hydrochloride Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006548,meperidine hydrochloride 50 mg per 1 mL solution for injection ampoule,N02AB02,Pethidine,Marketed,2005-10-05
8487,Human,00725749,Meperidine Hydrochloride Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9006625,meperidine hydrochloride 100 mg per 1 mL solution for injection ampoule,N02AB02,Pethidine,Cancelled post market,2021-04-23
36719,Human,02208148,Pethidine Injection B.P.,Hospira Healthcare Ulc,,,1,BC_MOH,,meperidine hydrochloride 10 mg / mL solution for injection,N02AB02,Pethidine,Cancelled post market,2012-08-03
84910,Human,02364174,Abstral,Paladin Pharma Inc.,,,1,CCDD_NTP,9001344,fentanyl (fentanyl citrate) 100 mcg sublingual tablet,N02AB03,Fentanyl,Cancelled post market,2018-06-29
84911,Human,02364182,Abstral,Paladin Pharma Inc.,,,1,CCDD_NTP,9001345,fentanyl (fentanyl citrate) 200 mcg sublingual tablet,N02AB03,Fentanyl,Cancelled post market,2018-06-29
84912,Human,02364190,Abstral,Paladin Pharma Inc.,,,1,CCDD_NTP,9001346,fentanyl (fentanyl citrate) 300 mcg sublingual tablet,N02AB03,Fentanyl,Cancelled post market,2018-06-29
84913,Human,02364204,Abstral,Paladin Pharma Inc.,,,1,CCDD_NTP,9001347,fentanyl (fentanyl citrate) 400 mcg sublingual tablet,N02AB03,Fentanyl,Cancelled post market,2018-06-29
84914,Human,02364212,Abstral,Paladin Pharma Inc.,,,1,CCDD_NTP,9001352,fentanyl (fentanyl citrate) 600 mcg sublingual tablet,N02AB03,Fentanyl,Cancelled post market,2018-06-29
84915,Human,02364220,Abstral,Paladin Pharma Inc.,,,1,CCDD_NTP,9001349,fentanyl (fentanyl citrate) 800 mcg sublingual tablet,N02AB03,Fentanyl,Cancelled post market,2018-06-29
80018,Human,02314630,Apo-Fentanyl Matrix,Apotex Inc,,,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-07-12
80019,Human,02314649,Apo-Fentanyl Matrix,Apotex Inc,,,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-02-20
80020,Human,02314657,Apo-Fentanyl Matrix,Apotex Inc,,,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-07-12
80021,Human,02314665,Apo-Fentanyl Matrix,Apotex Inc,,,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-07-12
94102,Human,02454440,Apo-Fentanyl Matrix,Apotex Inc,,,1,BC_MOH,,fentanyl 12 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled pre market,2018-07-30
87242,Human,02386844,Co Fentanyl,Cobalt Pharmaceuticals Company,,,1,CCDD_NTP,9001249,fentanyl 12 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-05-17
87243,Human,02386852,Co Fentanyl,Cobalt Pharmaceuticals Company,,,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-05-17
87244,Human,02386860,Co Fentanyl,Cobalt Pharmaceuticals Company,,,1,BC_MOH,,fentanyl 37 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled pre market,2018-05-17
87245,Human,02386879,Co Fentanyl,Cobalt Pharmaceuticals Company,,,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-05-17
87246,Human,02386887,Co Fentanyl,Cobalt Pharmaceuticals Company,,,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-05-17
87247,Human,02386895,Co Fentanyl,Cobalt Pharmaceuticals Company,,,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-05-17
76148,Human,02275813,Duragesic,Janssen Inc,,,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-10-31
76149,Human,02275821,Duragesic,Janssen Inc,,,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-10-31
76150,Human,02275848,Duragesic,Janssen Inc,,,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-10-31
76151,Human,02275856,Duragesic,Janssen Inc,,,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-10-31
81986,Human,02334186,Duragesic,Janssen Inc,,,1,CCDD_NTP,9001249,fentanyl 12 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-10-31
12659,Human,01937413,Duragesic 100,Janssen Inc,,,1,BC_MOH,,fentanyl 100 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled post market,2009-11-24
76602,Human,02280345,Duragesic 12,Janssen Inc,,,1,BC_MOH,,fentanyl 12 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled post market,2009-11-24
12656,Human,01937383,Duragesic 25,Janssen Inc,,,1,BC_MOH,,fentanyl 25 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled post market,2009-11-24
12657,Human,01937391,Duragesic 50,Janssen Inc,,,1,BC_MOH,,fentanyl 50 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled post market,2009-11-24
12658,Human,01937405,Duragesic 75,Janssen Inc,,,1,BC_MOH,,fentanyl 75 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled post market,2009-11-24
88073,Human,02395657,Fentanyl Patch,Pro Doc Limitee,,1,1,CCDD_NTP,9001249,fentanyl 12 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-11-01
88074,Human,02395665,Fentanyl Patch,Pro Doc Limitee,,1,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-11-01
88075,Human,02395673,Fentanyl Patch,Pro Doc Limitee,,1,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-11-01
88076,Human,02395681,Fentanyl Patch,Pro Doc Limitee,,1,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-11-01
88077,Human,02395703,Fentanyl Patch,Pro Doc Limitee,,1,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-11-01
78946,Human,02304155,Fentanyl Transdermal System 100,Actavis Group Ptc Ehf,,,1,BC_MOH,,fentanyl 100 mcg / hr transdermal prolonged-release patch,N02AB03,Fentanyl,Cancelled pre market,2018-09-04
78943,Human,02304120,Fentanyl Transdermal System 25,Actavis Group Ptc Ehf,,,1,BC_MOH,,fentanyl 25 mcg / hr transdermal prolonged-release patch,N02AB03,Fentanyl,Cancelled pre market,2018-09-04
78944,Human,02304139,Fentanyl Transdermal System 50,Actavis Group Ptc Ehf,,,1,BC_MOH,,fentanyl 50 mcg / hr transdermal prolonged-release patch,N02AB03,Fentanyl,Cancelled pre market,2018-09-04
78945,Human,02304147,Fentanyl Transdermal System 75,Actavis Group Ptc Ehf,,,1,BC_MOH,,fentanyl 75 mcg / hr transdermal prolonged-release patch,N02AB03,Fentanyl,Cancelled pre market,2018-09-04
89270,Human,02408007,Fentora,Teva Canada Limited,,1,1,CCDD_NTP,9001424,fentanyl (fentanyl citrate) 100 mcg buccal tablet,N02AB03,Fentanyl,Marketed,2014-05-14
89271,Human,02408015,Fentora,Teva Canada Limited,,1,1,CCDD_NTP,9001425,fentanyl (fentanyl citrate) 200 mcg buccal tablet,N02AB03,Fentanyl,Marketed,2014-05-14
89272,Human,02408023,Fentora,Teva Canada Limited,,1,1,CCDD_NTP,9001426,fentanyl (fentanyl citrate) 400 mcg buccal tablet,N02AB03,Fentanyl,Marketed,2014-05-14
89273,Human,02408031,Fentora,Teva Canada Limited,,1,1,CCDD_NTP,9001427,fentanyl (fentanyl citrate) 600 mcg buccal tablet,N02AB03,Fentanyl,Marketed,2014-05-14
89274,Human,02408058,Fentora,Teva Canada Limited,,1,1,CCDD_NTP,9001428,fentanyl (fentanyl citrate) 800 mcg buccal tablet,N02AB03,Fentanyl,Marketed,2014-05-14
89328,Human,02408546,Instanyl,Takeda Canada Inc,,,1,BC_MOH,,fentanyl (fentanyl citrate) 50 mcg / dose nasal solution,N02AB03,Fentanyl,Cancelled pre market,2016-07-11
89329,Human,02408562,Instanyl,Takeda Canada Inc,,,1,BC_MOH,,fentanyl (fentanyl citrate) 200 mcg / dose nasal solution,N02AB03,Fentanyl,Cancelled pre market,2016-07-11
89330,Human,02408554,Instanyl,Takeda Canada Inc,,,1,BC_MOH,,fentanyl (fentanyl citrate) 100 mcg / dose nasal solution,N02AB03,Fentanyl,Cancelled pre market,2016-07-11
88172,Human,02396696,Mylan-Fentanyl Matrix Patch,Mylan Pharmaceuticals Ulc,,,1,CCDD_NTP,9001249,fentanyl 12 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-12-31
88173,Human,02396718,Mylan-Fentanyl Matrix Patch,Mylan Pharmaceuticals Ulc,,,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-12-31
88174,Human,02396726,Mylan-Fentanyl Matrix Patch,Mylan Pharmaceuticals Ulc,,,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-12-31
88175,Human,02396734,Mylan-Fentanyl Matrix Patch,Mylan Pharmaceuticals Ulc,,,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-12-31
88176,Human,02396742,Mylan-Fentanyl Matrix Patch,Mylan Pharmaceuticals Ulc,,,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-12-31
83587,Human,02350661,Onsolis,Meda Ab,,,1,BC_MOH,,fentanyl (fentanyl citrate) 200 mcg buccal soluble film,N02AB03,Fentanyl,Cancelled post market,2013-01-31
83588,Human,02350688,Onsolis,Meda Ab,,,1,BC_MOH,,fentanyl (fentanyl citrate) 400 mcg buccal soluble film,N02AB03,Fentanyl,Cancelled post market,2013-01-31
83589,Human,02350696,Onsolis,Meda Ab,,,1,BC_MOH,,fentanyl (fentanyl citrate) 600 mcg buccal soluble film,N02AB03,Fentanyl,Cancelled post market,2013-01-31
83590,Human,02350718,Onsolis,Meda Ab,,,1,BC_MOH,,fentanyl (fentanyl citrate) 800 mcg buccal soluble film,N02AB03,Fentanyl,Cancelled post market,2013-01-31
83591,Human,02350726,Onsolis,Meda Ab,,,1,BC_MOH,,fentanyl (fentanyl citrate) 1200 mcg buccal soluble film,N02AB03,Fentanyl,Cancelled post market,2013-01-31
86235,Human,02376768,Pat-Fentanyl Mat,Patriot A Division Of Janssen Inc,,,1,BC_MOH,,fentanyl 12 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled pre market,2017-08-03
86236,Human,02376776,Pat-Fentanyl Mat,Patriot A Division Of Janssen Inc,,,1,BC_MOH,,fentanyl 25 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled pre market,2017-08-03
86237,Human,02376784,Pat-Fentanyl Mat,Patriot A Division Of Janssen Inc,,,1,BC_MOH,,fentanyl 50 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled pre market,2017-08-03
86238,Human,02376792,Pat-Fentanyl Mat,Patriot A Division Of Janssen Inc,,,1,BC_MOH,,fentanyl 75 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled pre market,2017-08-03
86239,Human,02376806,Pat-Fentanyl Mat,Patriot A Division Of Janssen Inc,,,1,BC_MOH,,fentanyl 100 mcg / hr transdermal patch,N02AB03,Fentanyl,Cancelled pre market,2017-08-03
82689,Human,02341379,Pms-Fentanyl Mtx,Pharmascience Inc,,,1,CCDD_NTP,9001249,fentanyl 12 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2023-06-05
82690,Human,02341387,Pms-Fentanyl Mtx,Pharmascience Inc,,,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2023-06-05
82691,Human,02341395,Pms-Fentanyl Mtx,Pharmascience Inc,,,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2023-06-05
82692,Human,02341409,Pms-Fentanyl Mtx,Pharmascience Inc,,,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2023-06-05
82693,Human,02341417,Pms-Fentanyl Mtx,Pharmascience Inc,,,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2023-06-05
81586,Human,02330105,Ran-Fentanyl Matrix Patch,Ranbaxy Pharmaceuticals Canada Inc.,,,1,CCDD_NTP,9001249,fentanyl 12 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-08-23
81587,Human,02330113,Ran-Fentanyl Matrix Patch,Ranbaxy Pharmaceuticals Canada Inc.,,,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-07-16
81588,Human,02330121,Ran-Fentanyl Matrix Patch,Ranbaxy Pharmaceuticals Canada Inc.,,,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2018-12-06
81589,Human,02330148,Ran-Fentanyl Matrix Patch,Ranbaxy Pharmaceuticals Canada Inc.,,,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-03-25
81590,Human,02330156,Ran-Fentanyl Matrix Patch,Ranbaxy Pharmaceuticals Canada Inc.,,,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Cancelled post market,2019-07-16
73424,Human,02249391,Ran-Fentanyl Transdermal System,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,fentanyl 2.5 mg transdermal patch,N02AB03,Fentanyl,Cancelled post market,2011-08-12
73425,Human,02249413,Ran-Fentanyl Transdermal System,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,fentanyl 5 mg transdermal patch,N02AB03,Fentanyl,Cancelled post market,2011-08-12
73426,Human,02249421,Ran-Fentanyl Transdermal System,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,fentanyl 7.5 mg transdermal patch,N02AB03,Fentanyl,Cancelled post market,2011-08-12
73427,Human,02249448,Ran-Fentanyl Transdermal System,Ranbaxy Pharmaceuticals Canada Inc.,,,1,BC_MOH,,fentanyl 10 mg transdermal patch,N02AB03,Fentanyl,Cancelled post market,2011-08-12
81243,Human,02327112,Sandoz Fentanyl Patch,Sandoz Canada Incorporated,,1,1,CCDD_NTP,9001249,fentanyl 12 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2010-11-01
81244,Human,02327120,Sandoz Fentanyl Patch,Sandoz Canada Incorporated,,1,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2010-11-01
81245,Human,02327139,Sandoz Fentanyl Patch,Sandoz Canada Incorporated,,1,1,CCDD_NTP,9001326,fentanyl 37 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2010-11-01
81246,Human,02327147,Sandoz Fentanyl Patch,Sandoz Canada Incorporated,,1,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2010-11-01
81247,Human,02327155,Sandoz Fentanyl Patch,Sandoz Canada Incorporated,,1,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2010-11-01
81248,Human,02327163,Sandoz Fentanyl Patch,Sandoz Canada Incorporated,,1,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2010-11-01
76857,Human,02282941,Teva-Fentanyl,Teva Canada Limited,,,1,CCDD_NTP,9001162,fentanyl 25 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2012-12-21
76858,Human,02282968,Teva-Fentanyl,Teva Canada Limited,,,1,CCDD_NTP,9001163,fentanyl 50 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2012-12-21
76859,Human,02282976,Teva-Fentanyl,Teva Canada Limited,,,1,CCDD_NTP,9001164,fentanyl 75 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2012-12-21
76860,Human,02282984,Teva-Fentanyl,Teva Canada Limited,,,1,CCDD_NTP,9001161,fentanyl 100 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2012-12-21
79746,Human,02311925,Teva-Fentanyl,Teva Canada Limited,,,1,CCDD_NTP,9001249,fentanyl 12 mcg per hour transdermal patch,N02AB03,Fentanyl,Marketed,2012-12-21
662,Human,00010081,642 Tab,Pendopharm Division Of Pharmascience Inc,,,1,BC_MOH,,dextropropoxyphene hydrochloride 65 mg oral tablet,N02AC04,Dextropropoxyphene,Cancelled post market,2010-11-25
1629,Human,00261432,Darvon-N,Paladin Pharma Inc.,,,1,BC_MOH,,dextropropoxyphene napsylate 100 mg oral capsule,N02AC04,Dextropropoxyphene,Cancelled post market,2010-12-23
902,Human,00151351,Novo-Propoxyn Cap 65Mg,Novopharm Limited,,,1,BC_MOH,,dextropropoxyphene hydrochloride 65 mg oral capsule,N02AC04,Dextropropoxyphene,Cancelled post market,2005-08-10
1156,Human,00108146,692 Tab,"Merck Frosst Canada & Cie, Merck Frosst Canada & Co.",,,3,BC_MOH,,acetylsalicylic acid 375 mg + caffeine 30 mg + dextropropoxyphene hydrochloride 65 mg oral tablet,N02AC54,"Dextropropoxyphene, comb excl psycholept",Cancelled post market,1998-04-21
55848,Human,02234509,692 Tablet,Lioh Inc.,,,3,BC_MOH,,acetylsalicylic acid 375 mg + caffeine 30 mg + dextropropoxyphene hydrochloride 65 mg oral tablet,N02AC54,"Dextropropoxyphene, comb excl psycholept",Cancelled post market,2006-08-25
1630,Human,00261459,Darvon N Compound Pulvule 405,Eli Lilly Canada Inc,,,3,BC_MOH,,acetylsalicylic acid 375 mg + caffeine 30 mg + dextropropoxyphene napsylate 100 mg oral capsule,N02AC54,"Dextropropoxyphene, comb excl psycholept",Cancelled post market,1999-08-11
1782,Human,00277118,Novo-Propoxyn Compound Cap,Novopharm Limited,,,3,BC_MOH,,acetylsalicylic acid 375 mg + caffeine 30 mg + dextropropoxyphene hydrochloride 65 mg oral capsule,N02AC54,"Dextropropoxyphene, comb excl psycholept",Cancelled post market,2005-08-10
18230,Human,02137984,Talwin,Sanofi-Aventis Canada Inc,,,1,CCDD_NTP,9000051,pentazocine (pentazocine hydrochloride) 50 mg oral tablet,N02AD01,Pentazocine,Cancelled post market,2021-02-19
65646,Human,02241976,Talwin,Pfizer Canada Ulc,,,1,CCDD_NTP,9006278,pentazocine (pentazocine lactate) 30 mg per 1 mL solution for injection ampoule,N02AD01,Pentazocine,Cancelled post market,2019-11-21
17750,Human,02139014,Talwin - Liq 30Mg/Ml,Sanofi-Synthelabo Canada Inc,,,1,BC_MOH,,pentazocine (pentazocine lactate) 30 mg / mL liquid for injection,N02AD01,Pentazocine,Cancelled post market,2001-08-10
98360,Human,02493608,Bar-Buprenorphine,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,buprenorphine 5 mcg / hr transdermal patch,N02AE01,Buprenorphine,Cancelled pre market,2024-04-15
98361,Human,02493616,Bar-Buprenorphine,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,buprenorphine 10 mcg / hr transdermal patch,N02AE01,Buprenorphine,Cancelled pre market,2024-04-15
98362,Human,02493624,Bar-Buprenorphine,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,buprenorphine 15 mcg / hr transdermal patch,N02AE01,Buprenorphine,Cancelled pre market,2024-04-15
98363,Human,02493632,Bar-Buprenorphine,Bard Pharmaceuticals (1990) Inc,,,1,BC_MOH,,buprenorphine 20 mcg / hr transdermal patch,N02AE01,Buprenorphine,Cancelled pre market,2024-04-15
95343,Human,02465221,Belbuca,Purdue Pharma,,,1,CCDD_NTP,9012467,buprenorphine (buprenorphine hydrochloride) 75 mcg buccal film,N02AE01,Buprenorphine,Cancelled post market,2019-05-31
95344,Human,02465248,Belbuca,Purdue Pharma,,,1,CCDD_NTP,9012464,buprenorphine (buprenorphine hydrochloride) 150 mcg buccal film,N02AE01,Buprenorphine,Cancelled post market,2019-05-31
95345,Human,02465256,Belbuca,Purdue Pharma,,,1,CCDD_NTP,9012465,buprenorphine (buprenorphine hydrochloride) 300 mcg buccal film,N02AE01,Buprenorphine,Cancelled post market,2019-05-31
95346,Human,02465264,Belbuca,Purdue Pharma,,,1,CCDD_NTP,9012466,buprenorphine (buprenorphine hydrochloride) 450 mcg buccal film,N02AE01,Buprenorphine,Cancelled post market,2019-05-31
95347,Human,02465272,Belbuca,Purdue Pharma,,,1,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 600 mcg buccal soluble film,N02AE01,Buprenorphine,Cancelled pre market,2019-05-31
95348,Human,02465280,Belbuca,Purdue Pharma,,,1,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 750 mcg buccal soluble film,N02AE01,Buprenorphine,Cancelled pre market,2019-05-31
95349,Human,02465299,Belbuca,Purdue Pharma,,,1,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 900 mcg buccal soluble film,N02AE01,Buprenorphine,Cancelled pre market,2019-05-31
82675,Human,02341212,Butrans 10,Purdue Pharma,1,,1,CCDD_NTP,9001315,buprenorphine 10 mcg per hour transdermal patch,N02AE01,Buprenorphine,Marketed,2010-05-26
93692,Human,02450771,Butrans 15,Purdue Pharma,1,,1,CCDD_NTP,9001459,buprenorphine 15 mcg per hour transdermal patch,N02AE01,Buprenorphine,Marketed,2016-06-15
82676,Human,02341220,Butrans 20,Purdue Pharma,1,,1,CCDD_NTP,9001316,buprenorphine 20 mcg per hour transdermal patch,N02AE01,Buprenorphine,Marketed,2010-05-26
82671,Human,02341174,Butrans 5,Purdue Pharma,1,,1,CCDD_NTP,9001317,buprenorphine 5 mcg per hour transdermal patch,N02AE01,Buprenorphine,Marketed,2010-05-26
66247,Human,02242504,Butorphanol Nasal Spray,Aa Pharma Inc,,,1,CCDD_NTP,9000913,butorphanol tartrate 10 mg per mL nasal spray,N02AF01,Butorphanol,Marketed,2015-04-17
68484,Human,02244508,Pms-Butorphanol,Pharmascience Inc,,,1,CCDD_NTP,9000913,butorphanol tartrate 10 mg per mL nasal spray,N02AF01,Butorphanol,Cancelled post market,2018-10-17
16843,Human,02113031,Stadol Ns - 10Mg/Ml Aem-Liq,Bristol-Myers Squibb Canada,,,1,BC_MOH,,butorphanol tartrate 10 mg / mL nasal liquid or metered-dose aerosol,N02AF01,Butorphanol,Cancelled post market,2004-08-04
15581,Human,01999656,Acet Codeine 60,Pharmascience Inc,,,2,CCDD_NTP,9000103,acetaminophen 300 mg and codeine phosphate 60 mg oral tablet,N02AJ06,Codeine and paracetamol,Cancelled post market,2018-12-31
7029,Human,00666149,Empracet-60,Glaxosmithkline Inc,,,2,BC_MOH,,acetaminophen 300 mg + codeine phosphate 60 mg oral tablet,N02AJ06,Codeine and paracetamol,Cancelled post market,2002-05-28
6824,Human,00621463,Teva-Lenoltec No. 4,Teva Canada Limited,,,2,CCDD_NTP,9000103,acetaminophen 300 mg and codeine phosphate 60 mg oral tablet,N02AJ06,Codeine and paracetamol,Marketed,2018-10-05
19250,Human,02163918,Tylenol With Codeine No. 4,Janssen Inc,,,2,CCDD_NTP,9000103,acetaminophen 300 mg and codeine phosphate 60 mg oral tablet,N02AJ06,Codeine and paracetamol,Cancelled post market,2020-09-25
81005,Human,02324628,Apo-Oxycodone/Acet,Apotex Inc,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Marketed,2009-05-22
17235,Human,01916548,Endocet,Bristol-Myers Squibb Canada,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled post market,2017-10-13
83157,Human,02346141,Ntp-Oxycodone Acetaminophen,Nt Pharma Canada Ltd,,,2,BC_MOH,,acetaminophen 325 mg + oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled pre market,2017-03-16
82197,Human,02336391,Nu-Oxycodone/Acet,Nu-Pharm Inc,,,2,BC_MOH,,acetaminophen 325 mg + oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled (unreturned annual),2018-03-28
81249,Human,02327171,Oxycodone-Acet,Pro Doc Limitee,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled post market,2019-11-01
84644,Human,02361361,Oxycodone/Acet,Sanis Health Inc,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled post market,2021-01-07
84476,Human,02359774,Oxycodone/Acetaminophen,Nt Pharma Canada Ltd,,,2,BC_MOH,,acetaminophen 325 mg + oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled pre market,2017-03-16
15514,Human,01916475,Percocet,Bristol-Myers Squibb Canada,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled post market,2017-08-23
13316,Human,01916491,Percocet-Demi,Bristol-Myers Squibb Canada,,,2,CCDD_NTP,9000396,acetaminophen 325 mg and oxycodone hydrochloride 2.5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled post market,2017-10-13
69866,Human,02245758,Pms-Oxycodone - Acetaminophen,Pharmascience Inc,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled post market,2018-10-29
66193,Human,02242468,Rivacocet,Laboratoire Riva Inc.,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Marketed,2001-12-12
12594,Human,01916327,Roxicet Tab,"Roxane Labs, Division Of Boehringer Ingelheim",,,2,BC_MOH,,acetaminophen 325 mg + oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Cancelled post market,1999-08-09
79356,Human,02307898,Sandoz Oxycodone/Acetaminophen,Sandoz Canada Incorporated,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Dormant,2025-07-28
5778,Human,00608165,Teva-Oxycocet,Teva Canada Limited,,,2,CCDD_NTP,9000094,acetaminophen 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ17,Oxycodone and paracetamol,Marketed,2017-07-07
15512,Human,01916483,Endodan,Bristol-Myers Squibb Canada,,,2,BC_MOH,,acetylsalicylic acid 325 mg + oxycodone hydrochloride 5 mg oral tablet,N02AJ18,Oxycodone and acetylsalicylic acid,Cancelled post market,2007-10-18
15513,Human,01916572,Percodan,Bristol-Myers Squibb Canada,,,2,BC_MOH,,acetylsalicylic acid 325 mg + oxycodone hydrochloride 5 mg oral tablet,N02AJ18,Oxycodone and acetylsalicylic acid,Cancelled post market,2009-06-26
15109,Human,01916556,Percodan-Demi,Bristol-Myers Squibb Canada,,,2,BC_MOH,,acetylsalicylic acid 325 mg + oxycodone hydrochloride 2.5 mg oral tablet,N02AJ18,Oxycodone and acetylsalicylic acid,Cancelled post market,2004-08-04
66107,Human,02242395,Rivacodan,Laboratoire Riva Inc.,,,2,BC_MOH,,acetylsalicylic acid 325 mg / tablet + oxycodone hydrochloride 5 mg / tablet oral tablet,N02AJ18,Oxycodone and acetylsalicylic acid,Cancelled pre market,2018-06-01
5777,Human,00608157,Teva-Oxycodan,Teva Canada Limited,,,2,CCDD_NTP,9000195,acetylsalicylic acid 325 mg and oxycodone hydrochloride 5 mg oral tablet,N02AJ18,Oxycodone and acetylsalicylic acid,Marketed,2017-12-21
79545,Human,02309785,Codofen,Paladin Pharma Inc.,,,2,BC_MOH,,hydrocodone bitartrate 7.5 mg + ibuprofen 200 mg oral tablet,N02AJ23,Hydrocodone and ibuprofen,Cancelled pre market,2018-07-17
65689,Human,02242018,Ibucodone,Paladin Pharma Inc.,,,2,BC_MOH,,hydrocodone bitartrate 7.5 mg + ibuprofen 200 mg oral tablet,N02AJ23,Hydrocodone and ibuprofen,Cancelled pre market,2018-07-17
96120,Human,02471965,Apo-Tapentadol,Apotex Inc,,,1,BC_MOH,,tapentadol (tapentadol hydrochloride) 50 mg oral immediate release tablet,N02AX06,Tapentadol,Approved,2022-02-17
96121,Human,02471973,Apo-Tapentadol,Apotex Inc,,,1,BC_MOH,,tapentadol (tapentadol hydrochloride) 75 mg oral immediate release tablet,N02AX06,Tapentadol,Approved,2022-02-17
96122,Human,02471981,Apo-Tapentadol,Apotex Inc,,,1,BC_MOH,,tapentadol (tapentadol hydrochloride) 100 mg oral immediate release tablet,N02AX06,Tapentadol,Approved,2022-02-17
84534,Human,02360373,Nucynta Cr,Janssen Inc,,,1,BC_MOH,,tapentadol (tapentadol hydrochloride) 50 mg oral prolonged-release tablet,N02AX06,Tapentadol,Cancelled post market,2014-08-19
84535,Human,02360381,Nucynta Cr,Janssen Inc,,,1,BC_MOH,,tapentadol (tapentadol hydrochloride) 100 mg oral prolonged-release tablet,N02AX06,Tapentadol,Cancelled post market,2014-08-19
84536,Human,02360403,Nucynta Cr,Janssen Inc,,,1,BC_MOH,,tapentadol (tapentadol hydrochloride) 150 mg oral prolonged-release tablet,N02AX06,Tapentadol,Cancelled post market,2014-09-30
84537,Human,02360411,Nucynta Cr,Janssen Inc,,,1,BC_MOH,,tapentadol (tapentadol hydrochloride) 200 mg oral prolonged-release tablet,N02AX06,Tapentadol,Cancelled post market,2014-12-04
84538,Human,02360438,Nucynta Cr,Janssen Inc,,,1,BC_MOH,,tapentadol (tapentadol hydrochloride) 250 mg oral prolonged-release tablet,N02AX06,Tapentadol,Cancelled post market,2015-03-25
90016,Human,02415577,Nucynta Extended-Release,Endo Operations Ltd.,,,1,CCDD_NTP,9005496,tapentadol (tapentadol hydrochloride) 50 mg prolonged-release oral tablet,N02AX06,Tapentadol,Marketed,2017-09-20
90017,Human,02415585,Nucynta Extended-Release,Endo Operations Ltd.,,,1,CCDD_NTP,9005492,tapentadol (tapentadol hydrochloride) 100 mg prolonged-release oral tablet,N02AX06,Tapentadol,Marketed,2017-10-03
90018,Human,02415593,Nucynta Extended-Release,Endo Operations Ltd.,,,1,CCDD_NTP,9005493,tapentadol (tapentadol hydrochloride) 150 mg prolonged-release oral tablet,N02AX06,Tapentadol,Marketed,2017-10-17
90019,Human,02415607,Nucynta Extended-Release,Endo Operations Ltd.,,,1,CCDD_NTP,9005494,tapentadol (tapentadol hydrochloride) 200 mg prolonged-release oral tablet,N02AX06,Tapentadol,Marketed,2017-11-28
90020,Human,02415615,Nucynta Extended-Release,Endo Operations Ltd.,,,1,CCDD_NTP,9005495,tapentadol (tapentadol hydrochloride) 250 mg prolonged-release oral tablet,N02AX06,Tapentadol,Marketed,2017-10-24
86409,Human,02378272,Nucynta Ir,Endo Operations Ltd.,,,1,CCDD_NTP,9005008,tapentadol (tapentadol hydrochloride) 50 mg oral tablet,N02AX06,Tapentadol,Marketed,2017-09-12
86410,Human,02378280,Nucynta Ir,Endo Operations Ltd.,,,1,CCDD_NTP,9005009,tapentadol (tapentadol hydrochloride) 75 mg oral tablet,N02AX06,Tapentadol,Marketed,2017-08-30
86411,Human,02378299,Nucynta Ir,Endo Operations Ltd.,,,1,CCDD_NTP,9005007,tapentadol (tapentadol hydrochloride) 100 mg oral tablet,N02AX06,Tapentadol,Marketed,2017-08-30
104353,Human,02554690,Apo-Butalbital-Acetylsalicylic Acid-Caffeine,Apotex Inc,,,3,CCDD_NTP,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Marketed,2025-05-08
1233,Human,00226327,Fiorinal,Aralez Pharmaceuticals Canada Inc,,,3,CCDD_NTP,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Marketed,2020-01-21
1852,Human,00275328,Fiorinal Tab,Novartis Pharmaceuticals Canada Inc,,,3,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg oral tablet,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Cancelled post market,2009-08-20
52473,Human,02232988,Pms-Pharnal Capsules,Pharmascience Inc,,,3,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg oral capsule,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Cancelled pre market,2017-08-03
52474,Human,02232989,Pms-Pharnal Tablets,Pharmascience Inc,,,3,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg oral tablet,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Cancelled pre market,2017-08-03
52470,Human,02232985,Pms-Pharnal-C 1/4 Capsules,Pharmascience Inc,,,4,BC_MOH,,acetylsalicylic acid 330 mg / capsule + butalbital 50 mg / capsule + caffeine 40 mg / capsule + codeine phosphate 15 mg / capsule oral capsule,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Cancelled pre market,2017-08-03
47953,Human,02229733,Pronal Capsules,Pro Doc Limitee,,,3,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg oral capsule,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Cancelled post market,2012-07-23
47956,Human,02229736,Pronal Tablets,Pro Doc Limitee,,,3,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg oral tablet,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Cancelled post market,2017-11-22
5779,Human,00608211,Teva-Tecnal,Teva Canada Limited,,,3,CCDD_NTP,9002002,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Marketed,2017-11-09
6480,Human,00608238,Teva-Tecnal,Teva Canada Limited,,,3,CCDD_NTP,9001668,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral capsule,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Marketed,2017-11-09
23672,Human,01971417,Trianal Capsules,Laboratoire Riva Inc.,,,3,BC_MOH,,acetylsalicylic acid 330 mg + butalbital 50 mg + caffeine 40 mg oral capsule,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Dormant,2017-07-05
23671,Human,01971409,Trianal Tablet,Laboratoire Riva Inc.,,,3,CCDD_NTP,9002002,acetylsalicylic acid 330 mg and butalbital 50 mg and caffeine 40 mg oral tablet,N02BA71,"Acetylsalicylic acid, comb with psycholeptics",Marketed,2015-11-23
225,Human,00000019,Placidyl Cap 200Mg,"Abbott Laboratories, Limited",,,1,BC_MOH,,ethchlorvynol 200 mg oral capsule,N05CM08,Ethchlorvynol,Cancelled post market,2008-06-10
226,Human,00000027,Placidyl Cap 500Mg,"Abbott Laboratories, Limited",,,1,BC_MOH,,ethchlorvynol 500 mg oral capsule,N05CM08,Ethchlorvynol,Cancelled post market,2008-06-06
1245,Human,00228893,Placidyl Cap 750Mg,"Abbott Laboratories, Limited",,,1,BC_MOH,,ethchlorvynol 750 mg oral capsule,N05CM08,Ethchlorvynol,Cancelled post market,2008-06-06
96515,Human,02474921,Probuphine,Knight Therapeutics Inc.,1,,1,CCDD_NTP,9013658,buprenorphine hydrochloride 80 mg implant,N07BC01,Buprenorphine,Cancelled post market,2023-06-30
97348,Human,02483084,Sublocade,Indivior Uk Limited,1,,1,CCDD_NTP,9014238,buprenorphine 100 mg per 0.5 mL prolonged-release solution for injection syringe,N07BC01,Buprenorphine,Marketed,2020-02-03
97349,Human,02483092,Sublocade,Indivior Uk Limited,1,,1,CCDD_NTP,9014239,buprenorphine 300 mg per 1.5 mL prolonged-release solution for injection syringe,N07BC01,Buprenorphine,Marketed,2020-02-03
102261,Human,02533642,Apo-Methadone,Apotex Inc,1,,1,CCDD_NTP,9001042,methadone hydrochloride 1 mg oral tablet,N07BC02,Methadone,Marketed,2024-03-08
102262,Human,02533650,Apo-Methadone,Apotex Inc,1,,1,CCDD_NTP,9001044,methadone hydrochloride 5 mg oral tablet,N07BC02,Methadone,Marketed,2024-03-08
102263,Human,02533669,Apo-Methadone,Apotex Inc,1,,1,CCDD_NTP,9001041,methadone hydrochloride 10 mg oral tablet,N07BC02,Methadone,Marketed,2024-03-08
102264,Human,02533677,Apo-Methadone,Apotex Inc,1,,1,CCDD_NTP,9001043,methadone hydrochloride 25 mg oral tablet,N07BC02,Methadone,Marketed,2024-03-08
98568,Human,02495783,Jamp Methadone Oral Concentrate,Jamp Pharma Corporation,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2020-10-30
65010,Human,02241377,Metadol,Endo Operations Ltd.,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2025-03-18
71958,Human,02247694,Metadol,Endo Operations Ltd.,1,,1,CCDD_NTP,9001034,methadone hydrochloride 1 mg per mL oral solution,N07BC02,Methadone,Marketed,2025-03-18
71959,Human,02247698,Metadol,Endo Operations Ltd.,1,,1,CCDD_NTP,9001042,methadone hydrochloride 1 mg oral tablet,N07BC02,Methadone,Marketed,2025-03-18
71963,Human,02247699,Metadol,Endo Operations Ltd.,1,,1,CCDD_NTP,9001044,methadone hydrochloride 5 mg oral tablet,N07BC02,Methadone,Marketed,2025-03-18
71964,Human,02247700,Metadol,Endo Operations Ltd.,1,,1,CCDD_NTP,9001041,methadone hydrochloride 10 mg oral tablet,N07BC02,Methadone,Marketed,2025-03-18
71965,Human,02247701,Metadol,Endo Operations Ltd.,1,,1,CCDD_NTP,9001043,methadone hydrochloride 25 mg oral tablet,N07BC02,Methadone,Marketed,2025-03-18
68257,Human,02244290,Metadol-D,Endo Operations Ltd.,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2025-04-15
71619,Human,02247374,Metadol-D,Endo Operations Ltd.,1,,1,CCDD_NTP,9001034,methadone hydrochloride 1 mg per mL oral solution,N07BC02,Methadone,Marketed,2025-04-15
71957,Human,02247693,Metadol-D,Paladin Pharma Inc.,1,,1,BC_MOH,,methadone hydrochloride 1 mg oral tablet,N07BC02,Methadone,Cancelled pre market,2021-07-28
71960,Human,02247695,Metadol-D,Paladin Pharma Inc.,1,,1,BC_MOH,,methadone hydrochloride 5 mg oral tablet,N07BC02,Methadone,Cancelled pre market,2021-07-28
71961,Human,02247696,Metadol-D,Paladin Pharma Inc.,1,,1,BC_MOH,,methadone hydrochloride 10 mg oral tablet,N07BC02,Methadone,Cancelled pre market,2021-07-28
71962,Human,02247697,Metadol-D,Paladin Pharma Inc.,1,,1,BC_MOH,,methadone hydrochloride 25 mg oral tablet,N07BC02,Methadone,Cancelled pre market,2021-07-28
97248,Human,02481979,Methadone Hydrochloride Oral Concentrate Usp,Sterinova Inc.,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Cancelled post market,2022-02-08
87974,Human,02394596,Methadose,Mallinckrodt Canada Ulc,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2013-01-03
87975,Human,02394618,Methadose,Mallinckrodt Canada Ulc,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2013-01-03
98577,Human,02495872,Odan-Methadone,Odan Laboratories Ltd,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2020-06-17
98578,Human,02495880,Odan-Methadone,Odan Laboratories Ltd,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2020-06-17
87392,Human,02388383,Pms-Methadone,Endo Operations Ltd.,1,,1,BC_MOH,,methadone hydrochloride 1 mg oral tablet,N07BC02,Methadone,Cancelled pre market,2025-08-29
87393,Human,02388391,Pms-Methadone,Endo Operations Ltd.,1,,1,BC_MOH,,methadone hydrochloride 5 mg oral tablet,N07BC02,Methadone,Cancelled pre market,2025-08-29
87394,Human,02388405,Pms-Methadone,Endo Operations Ltd.,1,,1,BC_MOH,,methadone hydrochloride 10 mg oral tablet,N07BC02,Methadone,Cancelled pre market,2025-08-29
87395,Human,02388413,Pms-Methadone,Endo Operations Ltd.,1,,1,BC_MOH,,methadone hydrochloride 25 mg oral tablet,N07BC02,Methadone,Cancelled pre market,2025-08-29
104168,Human,02552728,Pms-Methadone Hydrochloride Oral Concentrate,Pharmascience Inc,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2025-02-14
104169,Human,02552736,Pms-Methadone Hydrochloride Oral Concentrate,Pharmascience Inc,1,,1,CCDD_NTP,9001395,methadone hydrochloride 10 mg per mL oral solution,N07BC02,Methadone,Marketed,2025-02-14
101402,Human,02524996,Diacetylmorphine Hydrochloride,Pharmascience Inc,,,1,CCDD_NTP,9014809,diamorphine hydrochloride 200 mg per vial powder for solution for injection,N07BC06,Diamorphine,Marketed,2022-06-16
101403,Human,02525003,Diacetylmorphine Hydrochloride,Pharmascience Inc,,,1,CCDD_NTP,9014810,diamorphine hydrochloride 5000 mg per vial powder for solution for injection,N07BC06,Diamorphine,Marketed,2022-04-11
9409,Human,00781460,Diamorphine Hydrochloride Inj 100Mg/Ml Bp,Technilab Pharma Inc.,,,1,BC_MOH,,diamorphine hydrochloride 100 mg / mL powder for solution for injection,N07BC06,Diamorphine,Cancelled post market,1997-08-22
9281,Human,00781479,Diamorphine Hydrochloride Inj 30Mg/Ml Bp,Technilab Pharma Inc.,,,1,BC_MOH,,diamorphine hydrochloride 30 mg / mL powder for solution for injection,N07BC06,Diamorphine,Cancelled post market,1997-08-22
89278,Human,02408090,Mylan-Buprenorphine/Naloxone,Mylan Pharmaceuticals Ulc,1,,2,CCDD_NTP,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Cancelled post market,2019-09-17
89279,Human,02408104,Mylan-Buprenorphine/Naloxone,Mylan Pharmaceuticals Ulc,1,,2,CCDD_NTP,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Cancelled post market,2019-09-17
90952,Human,02424851,Pms-Buprenorphine-Naloxone,Pharmascience Inc,1,,2,CCDD_NTP,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Marketed,2017-11-24
90953,Human,02424878,Pms-Buprenorphine-Naloxone,Pharmascience Inc,1,,2,CCDD_NTP,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Marketed,2017-11-24
78104,Human,02295695,Suboxone,Indivior Uk Limited,1,,2,CCDD_NTP,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Marketed,2016-03-10
78105,Human,02295709,Suboxone,Indivior Uk Limited,1,,2,CCDD_NTP,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Marketed,2016-04-01
95646,Human,02468085,Suboxone,Indivior Uk Limited,1,,2,CCDD_NTP,9012472,buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Marketed,2018-02-14
95647,Human,02468093,Suboxone,Indivior Uk Limited,1,,2,CCDD_NTP,9012473,buprenorphine (buprenorphine hydrochloride) 16 mg and naloxone (naloxone hydrochloride) 4 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Marketed,2018-02-14
99189,Human,02502313,Suboxone,Indivior Uk Limited,1,,2,CCDD_NTP,9014448,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg oromucosal film,N07BC51,"Buprenorphine, combinations",Marketed,2021-01-20
99190,Human,02502321,Suboxone,Indivior Uk Limited,1,,2,CCDD_NTP,9014541,buprenorphine (buprenorphine hydrochloride) 4 mg and naloxone (naloxone hydrochloride) 1 mg oromucosal film,N07BC51,"Buprenorphine, combinations",Marketed,2021-06-17
99191,Human,02502348,Suboxone,Indivior Uk Limited,1,,2,CCDD_NTP,9014449,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg oromucosal film,N07BC51,"Buprenorphine, combinations",Marketed,2021-01-20
99192,Human,02502356,Suboxone,Indivior Uk Limited,1,,2,CCDD_NTP,9014447,buprenorphine (buprenorphine hydrochloride) 12 mg and naloxone (naloxone hydrochloride) 3 mg oromucosal film,N07BC51,"Buprenorphine, combinations",Marketed,2021-01-20
100651,Human,02517175,Taro-Buprenorphine/Naloxone,Taro Pharmaceuticals Inc,1,,2,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 2 mg + naloxone (naloxone hydrochloride dihydrate) 0.5 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Approved,2021-06-18
100652,Human,02517183,Taro-Buprenorphine/Naloxone,Taro Pharmaceuticals Inc,1,,2,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 8 mg + naloxone (naloxone hydrochloride dihydrate) 2 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Approved,2021-06-18
94043,Human,02453908,Teva-Buprenorphine/Naloxone,Teva Canada Limited,1,,2,CCDD_NTP,9001226,buprenorphine (buprenorphine hydrochloride) 2 mg and naloxone (naloxone hydrochloride) 0.5 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Marketed,2021-03-22
94044,Human,02453916,Teva-Buprenorphine/Naloxone,Teva Canada Limited,1,,2,CCDD_NTP,9001227,buprenorphine (buprenorphine hydrochloride) 8 mg and naloxone (naloxone hydrochloride) 2 mg sublingual tablet,N07BC51,"Buprenorphine, combinations",Marketed,2021-03-22
13315,Human,01916580,Hycodan Syrup,Bristol-Myers Squibb Canada,,,1,CCDD_NTP,9009884,hydrocodone bitartrate 5 mg per 5 mL syrup,R05DA03,Hydrocodone,Cancelled post market,2017-07-14
13314,Human,01916599,Hycodan Tablets,Bristol-Myers Squibb Canada,,,1,CCDD_NTP,9009882,hydrocodone bitartrate 5 mg oral tablet,R05DA03,Hydrocodone,Cancelled post market,2017-08-18
80973,Human,02324253,Pdp-Hydrocodone,Pendopharm Division Of Pharmascience Inc,,,1,CCDD_NTP,9009884,hydrocodone bitartrate 5 mg per 5 mL syrup,R05DA03,Hydrocodone,Marketed,2016-07-08
15182,Human,02041677,Robidone 1Mg/Ml Syr,Wyeth-Ayerst Canada Inc.,,,1,BC_MOH,,hydrocodone bitartrate 1 mg / mL oral syrup,R05DA03,Hydrocodone,Cancelled post market,2001-11-06
11547,Human,01923366,Robidone Syr 1Mg/Ml,Ayerst Laboratories,,,1,BC_MOH,,hydrocodone bitartrate 1 mg / mL oral syrup,R05DA03,Hydrocodone,Cancelled post market,1997-08-15
16475,Human,02009889,Codeine 15,Laboratoire Riva Inc.,,,1,CCDD_NTP,9000181,codeine phosphate 15 mg oral tablet,R05DA04,Codeine,Dormant,2021-11-05
16474,Human,02009757,Codeine 30,Laboratoire Riva Inc.,,,1,CCDD_NTP,9000182,codeine phosphate 30 mg oral tablet,R05DA04,Codeine,Marketed,2015-10-14
19050,Human,02163748,Codeine Contin 100Mg Controlled Release Tab,Purdue Pharma,,,1,CCDD_NTP,9000566,"codeine (codeine, codeine sulfate) 100 mg prolonged-release oral tablet",R05DA04,Codeine,Marketed,1995-12-31
19051,Human,02163780,Codeine Contin 150Mg Controlled Release Tab,Purdue Pharma,,,1,CCDD_NTP,9000567,"codeine (codeine, codeine sulfate) 150 mg prolonged-release oral tablet",R05DA04,Codeine,Marketed,1995-12-31
19049,Human,02163799,Codeine Contin 200Mg Controlled Release Tab,Purdue Pharma,,,1,CCDD_NTP,9000568,"codeine (codeine, codeine sulfate) 200 mg prolonged-release oral tablet",R05DA04,Codeine,Marketed,1995-12-31
49057,Human,02230302,Codeine Contin 50Mg Controlled Release Tab,Purdue Pharma,,,1,CCDD_NTP,9000709,"codeine (codeine, codeine sulfate) 50 mg prolonged-release oral tablet",R05DA04,Codeine,Marketed,1997-03-13
4232,Human,00497282,Codeine Phosphate Inj 30Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9000107,codeine phosphate 30 mg per 1 mL solution for injection ampoule,R05DA04,Codeine,Cancelled post market,2018-09-21
4233,Human,00497290,Codeine Phosphate Inj 60Mg/Ml,Hospira Healthcare Ulc,,,1,CCDD_NTP,9000166,codeine phosphate 60 mg per 1 mL solution for injection ampoule,R05DA04,Codeine,Cancelled post market,2018-09-21
4806,Human,00544884,Codeine Phosphate Injection Usp,Sandoz Canada Incorporated,,,1,CCDD_NTP,9000107,codeine phosphate 30 mg per 1 mL solution for injection ampoule,R05DA04,Codeine,Cancelled post market,2024-07-31
943,Human,00050024,Codeine Phosphate Syrup,Laboratoire Atlas Inc,,,1,CCDD_NTP,9006207,codeine phosphate 25 mg per 5 mL syrup,R05DA04,Codeine,Marketed,1986-12-18
1077,Human,00093114,Codeine Phosphate Syrup,D.C. Labs Limited,,,1,BC_MOH,,codeine phosphate 5 mg / mL oral syrup,R05DA04,Codeine,Cancelled post market,2005-07-19
1076,Human,00093122,Codeine Phosphate Tab 15Mg,D.C. Labs Limited,,,1,BC_MOH,,codeine phosphate 15 mg oral tablet,R05DA04,Codeine,Cancelled post market,2003-07-11
1075,Human,00093130,Codeine Phosphate Tab 30Mg,D.C. Labs Limited,,,1,BC_MOH,,codeine phosphate 30 mg oral tablet,R05DA04,Codeine,Cancelled post market,2003-07-11
1081,Human,00093149,Codeine Phosphate Tab 60Mg,D.C. Labs Limited,,,1,BC_MOH,,codeine phosphate 60 mg oral tablet,R05DA04,Codeine,Cancelled post market,2003-07-11
9439,Human,00779458,Codeine Tab 15Mg,Rougier Pharma Division Of Ratiopharm Inc,,,1,BC_MOH,,codeine phosphate 15 mg oral tablet,R05DA04,Codeine,Cancelled post market,2015-10-01
9912,Human,00779466,Codeine Tab 30Mg,Rougier Pharma Division Of Ratiopharm Inc,,,1,BC_MOH,,codeine phosphate 30 mg oral tablet,R05DA04,Codeine,Cancelled post market,1999-09-27
2982,Human,00380571,Linctus Codeine Blanc,Laboratoire Atlas Inc,,,1,CCDD_NTP,9006199,codeine phosphate 10 mg per 5 mL oral solution,R05DA04,Codeine,Marketed,1978-12-31
10996,Human,00779482,Paveral Liq 10Mg/Ml,Rougier Pharma Division Of Ratiopharm Inc,,,1,BC_MOH,,codeine phosphate 10 mg / mL oral liquid,R05DA04,Codeine,Cancelled post market,1999-09-27
67922,Human,02243978,Pms-Codeine,Pharmascience Inc,,,1,CCDD_NTP,9000181,codeine phosphate 15 mg oral tablet,R05DA04,Codeine,Cancelled post market,2019-04-04
67923,Human,02243979,Pms-Codeine,Pharmascience Inc,,,1,CCDD_NTP,9000182,codeine phosphate 30 mg oral tablet,R05DA04,Codeine,Cancelled post market,2019-04-04
8616,Human,00779474,Ratio-Codeine,Teva Canada Limited,,,1,BC_MOH,,codeine phosphate 5 mg / mL oral syrup,R05DA04,Codeine,Cancelled post market,2017-05-01
3591,Human,00470651,Stanley Syrup W Codeine Phosphate,"Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.",,,1,BC_MOH,,codeine phosphate 5 mg / mL oral syrup,R05DA04,Codeine,Cancelled post market,1997-08-08
6415,Human,00593435,Teva-Codeine,Teva Canada Limited,,,1,CCDD_NTP,9000181,codeine phosphate 15 mg oral tablet,R05DA04,Codeine,Marketed,2017-11-17
6416,Human,00593451,Teva-Codeine,Teva Canada Limited,,,1,CCDD_NTP,9000182,codeine phosphate 30 mg oral tablet,R05DA04,Codeine,Marketed,2017-11-17
4616,Human,00550485,Caldomine Dh Adulte,Technilab Pharma Inc.,,,4,BC_MOH,,hydrocodone bitartrate 5 mg / 5 mL + pheniramine maleate 12.5 mg / 5 mL + phenylpropanolamine hydrochloride 25 mg / 5 mL + pyrilamine maleate 12.5 mg / 5 mL oral liquid,R05DA20,Combinations,Cancelled post market,2001-04-04
5216,Human,00550493,Caldomine Dh Enfant,Technilab Pharma Inc.,,,4,BC_MOH,,hydrocodone bitartrate 1.667 mg / 5 mL + pheniramine maleate 6.25 mg / 5 mL + phenylpropanolamine hydrochloride 12.5 mg / 5 mL + pyrilamine maleate 6.25 mg / 5 mL oral liquid,R05DA20,Combinations,Cancelled post market,2001-04-04
864,Human,00116343,Cophylac,Hoechst Canada Inc.,,,2,BC_MOH,,normethadone hydrochloride 10 mg / mL + p-hydroxyephedrine hydrochloride 20 mg / mL oral drops,R05DA20,Combinations,Cancelled post market,1996-09-09
37358,Human,02224577,Cophylac,"Bausch Health, Canada Inc.",,,2,CCDD_NTP,9000695,normethadone hydrochloride 10 mg per mL and p-hydroxyephedrine hydrochloride 20 mg per mL oral drops,R05DA20,Combinations,Dormant,2022-07-28
14733,Human,01987577,Cophylac Drops,Hoechst Roussel Canada Inc.,,,2,BC_MOH,,normethadone hydrochloride 10 mg / mL + p-hydroxyephedrine hydrochloride 20 mg / mL oral drops,R05DA20,Combinations,Cancelled post market,1999-08-11
863,Human,00116351,Cophylac Expectorant,Hoechst Canada Inc.,,,3,BC_MOH,,emetine hydrochloride 1.3 mg / mL + normethadone hydrochloride 10 mg / mL + p-hydroxyephedrine hydrochloride 20 mg / mL oral drops,R05DA20,Combinations,Cancelled post market,1996-09-09
9811,Human,00791164,Coristine-Dh Liq,Technilab Pharma Inc.,,,2,BC_MOH,,hydrocodone bitartrate 1.7 mg / 5 mL + phenylephrine hydrochloride 10 mg / 5 mL oral syrup,R05DA20,Combinations,Cancelled post market,2006-07-28
5475,Human,00507407,Dalmacol,Laboratoire Atlas Inc,,,5,CCDD_NTP,9006201,alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrine hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup,R05DA20,Combinations,Cancelled post market,2025-04-23
50030,Human,02230769,Dalmacol,Laboratoire Riva Inc.,,,5,CCDD_NTP,9006201,alcohol anhydrous 0.25 mL per 5 mL and doxylamine succinate 6 mg per 5 mL and etafedrine hydrochloride 16.65 mg per 5 mL and hydrocodone bitartrate 1.65 mg per 5 mL and sodium citrate 200 mg per 5 mL syrup,R05DA20,Combinations,Marketed,1997-03-26
13802,Human,01916564,Hycomine,Bristol-Myers Squibb Canada,,,4,BC_MOH,,ammonium chloride 12 mg / mL + hydrocodone bitartrate 1 mg / mL + phenylephrine hydrochloride 2 mg / mL + pyrilamine maleate 2.5 mg / mL oral syrup,R05DA20,Combinations,Cancelled post market,2011-05-24
15544,Human,01916521,Hycomine-S,Bristol-Myers Squibb Canada,,,4,BC_MOH,,ammonium chloride 6 mg / mL + hydrocodone bitartrate 0.5 mg / mL + phenylephrine hydrochloride 1 mg / mL + pyrilamine maleate 1.25 mg / mL oral syrup,R05DA20,Combinations,Cancelled post market,2009-10-05
16637,Human,02048183,Mercodol With Decapryn,Aventis Pharma Inc,,,4,BC_MOH,,doxylamine succinate 6 mg / 5 mL + etafedrine hydrochloride 16.65 mg / 5 mL + hydrocodone bitartrate 1.65 mg / 5 mL + sodium citrate 200 mg / 5 mL oral syrup,R05DA20,Combinations,Cancelled post market,2001-07-20
16635,Human,02049481,Novahistex Dh,Sanofi-Aventis Canada Inc,,,2,CCDD_NTP,9002680,hydrocodone bitartrate 5 mg per 5 mL and phenylephrine hydrochloride 20 mg per 5 mL syrup,R05DA20,Combinations,Cancelled post market,2020-04-09
16640,Human,02049473,Novahistine Dh,Sanofi-Aventis Canada Inc,,,2,CCDD_NTP,9002679,hydrocodone bitartrate 1.7 mg per 5 mL and phenylephrine hydrochloride 10 mg per 5 mL syrup,R05DA20,Combinations,Cancelled post market,2020-07-10
4615,Human,00550477,Ratio-Calmydone,Teva Canada Limited,,,4,BC_MOH,,doxylamine succinate 1.2 mg / mL + etafedrine hydrochloride 3.33 mg / mL + hydrocodone bitartrate 0.33 mg / mL + sodium citrate 40 mg / mL oral syrup,R05DA20,Combinations,Cancelled post market,2017-04-04
7082,Human,00694827,Ratio-Coristex-Dh,Ratiopharm Inc Division Of Teva Canada Limited,,,2,BC_MOH,,hydrocodone bitartrate 5 mg / 5 mL + phenylephrine hydrochloride 20 mg / 5 mL oral syrup,R05DA20,Combinations,Cancelled post market,2015-08-21
13223,Human,01925962,Tussaminic Dh Forte Syrup,Novartis Consumer Health Canada Inc.,,,4,BC_MOH,,hydrocodone bitartrate 5 mg / 5 mL + pheniramine maleate 12.5 mg / 5 mL + phenylpropanolamine hydrochloride 25 mg / 5 mL + pyrilamine maleate 12.5 mg / 5 mL oral syrup,R05DA20,Combinations,Cancelled post market,2001-04-06
15490,Human,01906690,Tussaminic Dh Pediatric Syrup,Novartis Consumer Health Canada Inc.,,,4,BC_MOH,,hydrocodone bitartrate 1.667 mg / 5 mL + pheniramine maleate 6.25 mg / 5 mL + phenylpropanolamine hydrochloride 12.5 mg / 5 mL + pyrilamine maleate 6.25 mg / 5 mL oral syrup,R05DA20,Combinations,Cancelled post market,2001-04-06
12216,Human,01916971,Tussionex,Sanofi-Aventis Canada Inc,,,2,CCDD_NTP,9000017,hydrocodone 5 mg per 5 mL and phenyltoloxamine 10 mg per 5 mL oral suspension,R05DA20,Combinations,Cancelled post market,2020-01-29
12217,Human,01916963,Tussionex,Sanofi-Aventis Canada Inc,,,2,CCDD_NTP,9000016,hydrocodone 5 mg and phenyltoloxamine 10 mg prolonged-release oral tablet,R05DA20,Combinations,Cancelled post market,2017-08-24
4124,Human,00472549,Vasofrinic Dh,Laboratoires Trianon Inc.,,,3,BC_MOH,,chlorpheniramine maleate 2 mg / 5 mL + hydrocodone bitartrate 2.5 mg / 5 mL + pseudoephedrine hydrochloride 30 mg / 5 mL oral syrup,R05DA20,Combinations,Cancelled post market,2017-03-10
16821,Human,01987801,Cophylac Expectorant Drops,Hoechst Roussel Canada Inc.,,,3,BC_MOH,,emetine hydrochloride 1.3 mg / mL + normethadone hydrochloride 10 mg / mL + p-hydroxyephedrine hydrochloride 20 mg / mL oral drops,R05FA02,Opium derivatives and expectorants,Cancelled post market,1999-08-11
37359,Human,02224585,Cophylac Expectorant Drops,Valeo Pharma Inc,,,3,BC_MOH,,emetine hydrochloride 1.3 mg / mL + normethadone hydrochloride 10 mg / mL + p-hydroxyephedrine hydrochloride 20 mg / mL oral drops,R05FA02,Opium derivatives and expectorants,Cancelled post market,2004-11-03
68035,Human,02244080,Dimetane Expectorant Dc,"Foundation Consumer Brands, Llc",,,4,CCDD_NTP,9003646,brompheniramine maleate 2 mg per 5 mL and guaifenesin 100 mg per 5 mL and hydrocodone bitartrate 1.8 mg per 5 mL and phenylephrine hydrochloride 5 mg per 5 mL syrup,R05FA02,Opium derivatives and expectorants,Cancelled post market,2021-12-31
13632,Human,01934708,Dimetane Expectorant-Dc Syr,Whitehall-Robins Inc.,,,5,BC_MOH,,brompheniramine maleate 2 mg / 5 mL + guaifenesin 100 mg / 5 mL + hydrocodone bitartrate 1.8 mg / 5 mL + phenylephrine hydrochloride 5 mg / 5 mL + phenylpropanolamine hydrochloride 5 mg / 5 mL oral syrup,R05FA02,Opium derivatives and expectorants,Cancelled post market,2001-04-10
16639,Human,02049457,Novahistex Dh Expectorant,Aventis Pharma Inc,,,3,BC_MOH,,guaifenesin 200 mg / 5 mL + hydrocodone bitartrate 5 mg / 5 mL + phenylephrine hydrochloride 20 mg / 5 mL oral syrup,R05FA02,Opium derivatives and expectorants,Cancelled post market,2003-07-22
9913,Human,00779512,Solucodan Syrup,Rougier Pharma Division Of Ratiopharm Inc,,,4,BC_MOH,,hydrocodone bitartrate 2 mg / 5 mL + menthol 2.5 mg / 5 mL + potassium guaiacol sulphonate 80 mg / 5 mL + sodium citrate 100 mg / 5 mL oral syrup,R05FA02,Opium derivatives and expectorants,Cancelled post market,1999-09-27
8617,Human,00779504,Solucodan-H,Rougier Pharma Division Of Ratiopharm Inc,,,5,BC_MOH,,diphenylpyraline hydrochloride 1.5 mg / 5 mL + hydrocodone bitartrate 2 mg / 5 mL + menthol 2.5 mg / 5 mL + potassium guaiacol sulphonate 80 mg / 5 mL + sodium citrate 100 mg / 5 mL oral syrup,R05FA02,Opium derivatives and expectorants,Cancelled post market,1999-09-27
15203,Human,01906615,Triaminic Expectorant Dh Syrup,Novartis Consumer Health Canada Inc.,,,5,BC_MOH,,guaifenesin 100 mg / 5 mL + hydrocodone bitartrate 1.67 mg / 5 mL + pheniramine maleate 6.25 mg / 5 mL + phenylpropanolamine hydrochloride 12.5 mg / 5 mL + pyrilamine maleate 6.25 mg / 5 mL oral syrup,R05FA02,Opium derivatives and expectorants,Cancelled post market,2001-04-06
101541,Veterinary,02526301,Bupaq,Vetviva Richter Gmbh,,,1,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 0.3 mg / mL solution for injection,,,Marketed,2024-05-29
102020,Veterinary,02531143,Buprenol,Champion Alstoe Animal Health Inc.,,,1,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 0.3 mg / mL solution for injection,,,Marketed,2023-12-08
103108,Veterinary,02542536,Buprixa,Zoetis Canada Inc,,,1,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 0.3 mg / mL solution for injection,,,Approved,2024-01-30
98650,Veterinary,02496658,Comfortan,Eurovet Animal Health B.V.,,,1,BC_MOH,,methadone hydrochloride 10 mg / mL solution for injection,,,Marketed,2020-11-05
95081,Veterinary,02462923,Dolorex,Intervet Canada Corp,,,1,BC_MOH,,butorphanol (butorphanol tartrate) 10 mg / mL solution for injection,,,Marketed,2018-01-30
9436,Veterinary,00755672,Innovar-Vet Inj,Janssen,,,2,BC_MOH,,droperidol 20 mg / mL + fentanyl citrate 0.628 mg / mL solution for injection,,,Cancelled post market,2004-08-04
10672,Veterinary,00845000,Torbugesic,Zoetis Canada Inc,,,1,BC_MOH,,butorphanol (butorphanol tartrate) 10 mg / mL solution for injection,,,Marketed,2017-03-15
11817,Veterinary,00844977,Torbutrol,Zoetis Canada Inc,,,1,BC_MOH,,butorphanol (butorphanol tartrate) 1 mg oral tablet,,,Dormant,2023-07-27
11822,Veterinary,00844985,Torbutrol,Zoetis Canada Inc,,,1,BC_MOH,,butorphanol (butorphanol tartrate) 5 mg oral tablet,,,Dormant,2023-07-27
11823,Veterinary,00844993,Torbutrol (Butorphanol Tartrate 10Mg Tablet),"Wyeth Animal Health, Division Of Wyeth Canada",,,1,BC_MOH,,butorphanol (butorphanol tartrate) 10 mg oral tablet,,,Cancelled post market,2011-07-21
98628,Veterinary,02496402,Torphadine,Dechra Regulatory Bv,,,1,BC_MOH,,butorphanol (butorphanol tartrate) 10 mg / mL solution for injection,,,Marketed,2020-10-21
82800,Veterinary,02342510,Vetergesic Multidose,Ceva Animal Health Inc,,,1,BC_MOH,,buprenorphine (buprenorphine hydrochloride) 0.3 mg / mL solution for injection,,,Marketed,2019-09-12
